Trading Analysis Report: ARM¶

Analysis date: 2026-10-14
Rating: Underweight
Generated: 2026-10-14 17:17:34
TradingAgents 0.6.0: anthropic, deep claude-opus-5-5, quick claude-sonnet-5-5
Analysts: market, sentiment, news, fundamentals; research debate rounds 5, risk debate rounds 5
Data vendors: core_stock_apis yfinance, technical_indicators yfinance, fundamental_data sec_edgar,yfinance, news_data yfinance, macro_data fred, prediction_markets polymarket

I. Analyst Team Reports¶

Market Analyst¶

Current Price: 238.01 Price As Of: 2026-10-14

ARM (Arm Holdings plc, Technology / Semiconductors, NMS): Technical Report¶

The tools don't state a currency. I'm assuming USD from the NMS listing. Every exact figure below comes from the verified snapshot or from the dated tool output. Percentages marked "derived" are my own arithmetic on those tool values.

1. Data integrity notes¶

The tools agree. The close, RSI, MACD histogram, Bollinger lower band and 200 SMA from the indicator calls all match the verified snapshot. I found no discrepancies.
Today's bar may be incomplete. The 2026-10-14 volume is 6,550,839. Every other row in the series ends in "00", so this one looks like a live or partial print. If the session is still open, the close, volume and every indicator below can still move. OBV fell by exactly 6,550,839 from 10-13 to 10-14, so the OBV calculation uses that volume as printed.
Tool gaps. I did not pull ADX, so I can't quantify trend strength. I also have no news, earnings or fundamental data. The catalyst behind the large moves below is unknown to me.

2. Price structure (April to October 2026)¶

The window shows one full boom-and-bust cycle.

Run-up: the close went from 159.34 (04-15) to a peak close of 439.46 (06-18). The peak intraday high was 452.70 on the same day, on very heavy volume of 34.2M.
Distribution and decline: from 06-18 the stock made lower highs and lower lows through July. The close bottomed at 224.89 on 07-29, and the intraday low was 219.39 on 08-03.
Base building (August to mid-September): closes ranged roughly 234–285. Examples are 234.82 on 09-01 and 239.01 on 09-14.
September spike: the close rose from 243.98 (09-16) to 333.20 (09-22), a derived gain of about 37% in four sessions. The 09-21 session gapped up (open 294.36 after a 275.61 close) on 13.0M shares.
Full round trip: at 238.01, ARM is now below the pre-spike close of 243.98 on 09-16. Since the 09-22 close of 333.20 it has dropped about 28.6% (derived).
Recent selling: the stock is down about 22.6% from 307.49 (10-02). Four of the last five sessions were down:
10-08: about -6.5%
10-09: about -3.3%
10-12: about -4.2%
10-13: flat, +0.06%
10-14: about -6.8%
Drawdown from the peak: the close is about 45.8% below the 06-18 peak close (derived).
Today's candle: it opened at 248.00, below the prior close of 255.39. It ranged 237.55–250.20 and closed 0.46 above the low. The rebound attempt on 10-13 (low 243.60, high 260.15, close 255.39, volume 6.78M) failed the next day.

The swing highs of 439.46, 333.20 and 307.49 are each lower. The swing lows near 224.89 (07-29), 234.82 (09-01) and now about 238 have been roughly flat. That reads as a downtrend that is retesting a base, not a clean breakdown yet.

3. Trend¶

Measure	Value	Read
Close	238.01	Reference
10 EMA	270.25	Price about 11.9% below (derived)
50 SMA	269.65	Price about 11.7% below (derived)
200 SMA	222.19	Price about 7.1% above (derived)

Short and medium term are bearish. Price is well below both the 10 EMA and the 50 SMA. The two averages sit almost on top of each other (270.25 vs 269.65), so overhead resistance is concentrated around 270.
The long-term anchor is intact. The 200 SMA has risen every session in the window, from 204.83 (09-14) to 222.19 (10-14), about +0.7 per day recently. If price drifts lower, the 200 SMA keeps climbing toward it. At the current slope it would be near 225–226 in a week. That is an extrapolation, not a tool output.
SuperTrend, weighted weekly > monthly > daily:
Weekly (Tier 1): DOWN. The stop is 383.15 and the close is 37.88% below it. This is the primary trend, and it is bearish.
Monthly (Tier 2): UP. The stop is 198.17 and the close is 20.10% above it. The multi-month regime has not flipped.
Daily (Tier 3): DOWN. The stop is 295.73 and the close is 19.52% below it.
The timeframes conflict. The higher tier is the weekly, so the primary trend is down. The monthly uptrend gives regime context and a clear invalidation line near 198.

4. Momentum¶

MACD: the line is -3.75, the signal is 3.87 and the histogram is -7.62.
The histogram peaked at 10.86 on 09-23, crossed below zero on 10-07 (-0.27), and has fallen on each of the last eight sessions since 10-02 (1.26).
It is still making new lows (-7.62). There is no sign of momentum bottoming yet.
RSI (14): 35.87, down from 71.36 on 09-22.
It is the lowest reading in the 30-day window. The window low before today was 42.93 on 09-14.
It is below 40 but not yet below the 30 oversold line, so RSI alone doesn't confirm an exhausted sell-off.

5. Volatility and stretch¶

Bollinger lower band: 238.05, and the close is 238.01. Price is sitting essentially on the lower band, 0.04 below it.
The band has risen from 200.39 (09-23) as volatility has changed.
The middle (290.12) and upper (342.19) bands are still inflated by the 09-17 to 09-23 spike in the 20-day window. They should drift lower mechanically as those days roll off, unless price rises.
ATR (14): 17.28, about 7.3% of price (derived). This is a high-volatility name, and daily moves near 6–7% are common right now.
One ATR below the close is about 220.7 and one ATR above is about 255.3 (derived).
Those land near the 200 SMA and 08-03 low area on the downside, and near the last two closes (255.24 and 255.39) on the upside.
Z-score (20-period):
Weekly (Tier 1): -1.05, below the mean but not stretched.
Monthly (Tier 2): +0.70, near the mean.
Daily (Tier 3): -2.00, right at the stretched/oversold threshold.
Only the daily is stretched. The higher timeframes don't show a deep capitulation, so any bounce has weaker mean-reversion support from the weekly and monthly.

6. Volume and exhaustion¶

OBV: 406.50M on 10-14, down from 437.66M (09-22) and 430.05M (10-02). The decline is steady, not a collapse. It is still about 8.9M above the 09-14 level of 397.64M, when the close was nearly the same (239.01).
Net volume flow across the round trip has not fully erased the September accumulation.
The slope is negative, so selling is confirmed.
Volume pattern: the sell-off in late September was heavy, with 9.56M on 09-24 and 9.10M on 09-28. Early October pullback days ran around 3M. Volume then picked up again on 10-08 (6.20M), 10-13 (6.78M) and 10-14 (6.55M, possibly partial).
TD Sequential (buy-setup counts):
Weekly: +1 of 9.
Monthly: +2 of 9.
Daily: +5 of 9.
Only the daily is advanced, and it isn't complete. Under the standard DeMark convention, a daily 9 would need four more consecutive qualifying lower closes. The earliest date would be about 10-20, and the final bar would need to close below 238.01. This is an inference from the convention, not a tool output.
The weekly and monthly counts are early, so there is no higher-timeframe exhaustion signal.

7. Reference levels (from tool data, not validated as support or resistance)¶

Upside

Level	Source
250.20	Today's high
255.24 / 255.39	Closes on 10-12 and 10-13
269.65–270.25	50 SMA and 10 EMA cluster
290.12	Bollinger middle band
295.73	Daily SuperTrend stop
342.19	Bollinger upper band
383.15	Weekly SuperTrend stop

Downside

Level	Source
238.05	Bollinger lower band (price is on it now)
233.29	08-24 low
234.82	09-01 close
229.30	09-01 low
225.46	09-03 low
222.19	200 SMA
219.39	08-03 intraday low
198.17	Monthly SuperTrend stop

The 219–226 zone has several data points in it: the 200 SMA, the 07-29 and 08-03 lows, and the 09-03 low. After each of those lows, the next session closed higher: - 07-29 close of 224.89, then 241.54 on 07-30. - 08-03 close of 239.06, then 280.56 on 08-04. - 09-03 close of 242.59, then 252.09 on 09-04.

That is three observations, which is thin evidence. It doesn't establish that the level will hold.

8. Scenarios the data supports¶

Bearish continuation:
Evidence: momentum is still deteriorating (MACD histogram at new lows), the weekly and daily SuperTrends are down, price is below the 10 EMA and 50 SMA, OBV is sloping down, and RSI has room before oversold.
A decisive close below about 233–234 would open the 219–226 zone and the 200 SMA.
A close below 198.17 on the monthly SuperTrend would put the multi-month regime in doubt.
Oversold bounce:
Evidence: price is on the lower Bollinger band, the daily z-score is -2.00, RSI is in the mid-30s, the daily TD count is 5, and the 200 SMA is just below.
A relief move would first meet the 250–255 area, then the 270 cluster. The daily SuperTrend flip level of 295.73 is far away (about 24% higher, derived).
A bounce without a MACD histogram turn or a volume improvement would be lower quality.

My technical lean is bearish on the primary (weekly) trend, with the daily timeframe stretched enough that a bounce is plausible. The trade decision is for the next agent.

9. Risk notes¶

ATR is about 7.3% of price, so position size and stop distance need to account for large daily swings.
ARM has had several single-day moves of 15% or more in this window:
04-24: about +14.8%.
06-01: about +15.7%.
06-23: about -10.1%.
09-21: about +17.2%.
Check the earnings calendar and news. My tools can't verify event dates.
The 10-14 bar may still change if it isn't final.

10. Summary table¶

Item	Reading	Interpretation
Close (2026-10-14)	238.01	About 45.8% below the 06-18 peak close of 439.46 (derived); bar may be partial
10 EMA / 50 SMA	270.25 / 269.65	Price about 12% below both; short and medium term bearish
200 SMA	222.19 (rising)	Price about 7% above; long-term support intact
SuperTrend weekly (Tier 1)	DOWN, stop 383.15	Primary trend is down
SuperTrend monthly (Tier 2)	UP, stop 198.17	Regime intact; stop is a major invalidation line
SuperTrend daily (Tier 3)	DOWN, stop 295.73	Short-term trend is down
MACD / signal / histogram	-3.75 / 3.87 / -7.62	Bearish; histogram has fallen eight sessions in a row
RSI (14)	35.87	Weak, not yet oversold (<30)
Bollinger lower / middle / upper	238.05 / 290.12 / 342.19	Price sits on the lower band; middle and upper bands inflated by the September spike
ATR (14)	17.28 (about 7.3%)	High volatility; size positions accordingly
Z-score weekly / monthly / daily	-1.05 / +0.70 / -2.00	Only the daily is stretched
TD-9 weekly / monthly / daily	+1 / +2 / +5	Daily setup in progress; no higher-timeframe exhaustion
OBV	406.50M (peak 437.66M on 09-22)	Declining; still above the 09-14 level of 397.64M
Key downside zone	About 219–234	Prior lows, the 200 SMA and the lower-band area; not validated
Key upside zone	250–255, then about 270	Recent closes, then the 10 EMA and 50 SMA cluster
Data caveats	No ADX, news or earnings data pulled	Trend strength and catalysts are unverified

Sentiment Analyst¶

Overall Sentiment: Mildly Bullish (Score: 5.6/10) Confidence: Low

Scope and data limits. This report covers ARM (Arm Holdings plc) for 2026-10-07 to 2026-10-14. Three limits make the read less robust. (1) Reddit was disabled by config, so there is no Reddit signal at all. (2) The news feed has headlines and sources only, with no article bodies, no per-article dates and no price data. (3) StockTwits has 30 messages spanning roughly 2026-10-13 20:00Z to 2026-10-14 20:46Z, so it reflects about one day of reaction to the verdict, not the full week. Only 14 of the 30 messages carry a user sentiment tag. I have no verified price series, so the price levels below are quoted from users and are unconfirmed.

1. Source-by-source breakdown

News (Yahoo Finance, 13 headlines). The dominant story is the Delaware jury verdict in the Qualcomm-Arm licensing dispute, which appears in about 6 of 13 headlines. - Negative price-reaction framing: 'Why Arm Holdings Stock Was Falling Today' (Motley Fool), 'Arm shares fall after jury rules in favor of Qualcomm in license dispute' (Investing.com), and 'How Qualcomm's Legal Win Over Arm Could Reshape the Long-Term Thesis for QCOM Investors' (Simply Wall St.). - Neutral or ambiguous: 'Delaware Jury Delivers Verdict' (Stocktwits), 'Arm Holdings Has a $4.9 Billion Business Model on Trial' (Barchart), and the TIKR headline 'Trial Ends in Hung Jury'. The TIKR headline conflicts with the others, and without article text or dates I cannot tell whether it is stale, refers to a different phase, or is a framing difference. - Constructive: 'Heavy Unusual Call Option Activity in Chip Designer Arm Holdings' (Barchart, a bullish positioning signal), an AI ecosystem award (Simply Wall St.), 'How Arm Could Make Qualcomm Pay More' (Barchart), and two Insider Monkey pieces on Arm reshaping computing and on specialized-computing demand outlasting near-term shortages. - Filler or comparison pieces: Arm vs. Sandisk (Motley Fool) and an IBM earnings preview (Zacks), neither with a clear ARM directional signal. - Net: headline flow is event-heavy and mixed. The immediate price reaction was negative, while the secondary and longer-horizon commentary leans constructive. These are headlines only, so I cannot assess depth or tone beyond the titles.

StockTwits (30 messages). The tags are Bullish 12 (40%), Bearish 2 (7%) and unlabeled 16 (53%). - Among tagged posts the split is 12:2, about 86% bullish. That is a strong skew, but the base is only 14 tagged posts and the bulls are concentrated: @jd4308 wrote 3 of the 12 bullish posts and @BMakingMoney wrote 2, so there are about 9 unique bullish authors. Two bullish posts are only tangentially about ARM ($GFS/$INTC in @2moontrader's post, and an $AIP tie-in). - Bullish content is mostly dip-buying and technical. Examples: 'who bought the dip?', 'small blip as part of a bigger story', '$240 was gap fill', 'close over $245 is monumental', and the company's statement that the jury found for Arm on four claims and awarded only $1 on each of Qualcomm's other two claims. - The 2 bearish tags are thin on substance ('will be under 200 by next week', 'this will collapse hard'). - Unlabeled posts contain both camps. Skeptical: @BeauvoirDeBull says ARM is 'down -40% since' an earlier event, calls CEO Haas the 'worst CEO in Silicon Valley' for competing with customers, and sets a $150 PT; @brahms1833 is plainly negative. Constructive trade setups: @peloswing says 'still good above $240' with a $235 stop; @HungryMoney likes $320 Nov calls, with a better look under $242; @NezuRIP expects +8-14% if TSMC earnings are good. - Several posts are noise: a paid-alert promo (@TheNextTrillionaire), a BlackBerry/QNX post, a bare cashtag post, a news-recap bot, and a $QCOM-focused post. One speculative post ('judge denies the 5 year pause... $452 before Xmas') is unverifiable and I cannot tell what motion it refers to. - Net: retail is leaning into the dip with a bullish tilt, but the sample is small and one-day, with a few promotional and hype-driven accounts.

Reddit. No data. I cannot say anything about r/wallstreetbets, r/stocks or r/investing sentiment.

2. Cross-source divergences and alignments - Divergence: news framing on the verdict day was negative on price ('shares fall'), while tagged retail posts were mostly bullish and treated the drop as a buying opportunity. The retail read of the verdict as a partial win for Arm (four claims, $1 damages per Qualcomm claim) conflicts with headlines framing it as a Qualcomm win. - Alignment: both sources agree the legal verdict is the central driver and that the stock sold off on it. Unusual call activity (Barchart) and the dip-buying tone on StockTwits point the same way, toward speculative upside positioning. - Caution: dip-buying enthusiasm and options activity can be momentum-chasing. The retail view is also partly driven by self-reinforcing price-level talk ($240/$245 gap fill), which is technical rather than fundamental.

3. Dominant narrative themes 1. Qualcomm-Arm litigation outcome. Interpretations differ: a Qualcomm win on two claims versus Arm winning four claims with token $1 damages. Ongoing uncertainty about post-verdict next steps ('are we screwed or not screwed'). 2. Buy-the-dip and gap-fill technicals around $235-$245. 3. Arm's licensing leverage and AI/specialized-compute positioning (Barchart, Insider Monkey, award coverage). 4. Strategy and management criticism: Arm competing with its own customers, and a user claim of a roughly 40% drawdown since that shift (unverified). 5. Broader semis volatility: the 'sky is falling' and 'who bought the dip' posts mention $MRVL, $AVGO, $AMD and $NVDA, which suggests the pullback is not purely ARM-specific. This is inferred from a few posts only.

4. Catalysts and risks surfaced by the data - Catalysts: further court or post-trial developments (details not provided); TSMC earnings, cited by one user as a possible trigger for a short squeeze (a single speculative post); options expiry positioning into Friday ('rip into Friday', one post); continued AI-ecosystem and licensing-economics narratives; unusual call buying. - Risks: a legal and licensing precedent that could limit Arm's ability to raise royalties (the '$4.9 billion business model on trial' framing); a customer-relations backlash if Arm pushes into its own silicon; a technical breakdown below the $235-$242 area that retail is anchoring on, with bears targeting $200 or $150; semis-sector weakness; and possible crowded or promotional retail positioning. - Not covered by the sources: fundamentals, valuation, earnings dates, analyst rating changes, and price/volume data. The trader should check those separately.

5. Summary table

Signal	Direction	Source	Evidence
Verdict price reaction	Bearish (short-term)	News	'Why Arm Holdings Stock Was Falling Today'; 'Arm shares fall after jury rules in favor of Qualcomm'
Verdict substance	Mixed	News / StockTwits	Arm won 4 claims; Qualcomm got $1 on each of 2 claims (per user-quoted Arm statement/Reuters); TIKR 'hung jury' headline conflicts
Tagged retail ratio	Bullish	StockTwits	12 Bullish vs 2 Bearish of 14 tagged; 16 of 30 unlabeled; 9 unique bullish authors, @jd4308 posted 3
Dip-buying tone	Bullish	StockTwits	'who bought the dip?', 'small blip', '$240 gap fill', '$235 SL'
Options positioning	Bullish	News (Barchart)	'Heavy Unusual Call Option Activity'; user eyeing $320 Nov calls
Management/strategy criticism	Bearish	StockTwits	'worst CEO', 'down -40%', $150 PT (unlabeled, unverified)
Bear price targets	Bearish	StockTwits	'under 200 by next week', 'collapse hard' (2 tagged posts, low substance)
AI/licensing thesis	Mildly Bullish	News	AI ecosystem award; 'Make Qualcomm Pay More'; specialized-compute demand pieces
Sector pullback	Bearish/Neutral	StockTwits	$MRVL/$AVGO/$AMD/$NVDA dip chatter, a few posts only
Upcoming catalyst	Neutral/Bullish	StockTwits	TSMC earnings speculation (+8-14% claim), single user, unverified
Reddit coverage	Missing	Reddit	Disabled by config; no signal

Bottom line. Sentiment is mildly bullish but low-confidence. Retail is leaning into the post-verdict dip and the tagged ratio skews bullish, while news flow shows a negative immediate price reaction and ambiguous legal framing. The data cover about one day of social chatter, headlines only and no Reddit, so the trader should weigh this alongside fundamentals, price action and the details of the court outcome. Past sentiment is not predictive.

News Analyst¶

ARM (Arm Holdings plc, NMS): News and Macro Report, week of 2026-10-07 to 2026-10-14¶

Data coverage and limits¶

FRED macro data was unavailable. Every get_macro_indicators call (fed funds, 10Y, yield curve, CPI, core PCE, unemployment, VIX) failed because FRED_API_KEY is not set. I have no hard readings for these, and I have not estimated any. Macro commentary below rests on news headlines and prediction markets only.
The news tools returned headlines and links only, with no article text. I have no ARM price, percentage move, or volume figures. Where a headline conflicts with another or is ambiguous, I say so.
Prediction-market coverage is thin for single stocks. Nvidia, semiconductor tariffs, and oil price returned nothing. The "Qualcomm Arm" query returned only irrelevant Trump-word markets.

1. ARM company news¶

The main driver is the Qualcomm–Arm licensing litigation. The headlines say: - "Arm shares fall after jury rules in favor of Qualcomm in license dispute" (Investing.com) - "ARM-QCOM Lawsuit: Delaware Jury Delivers Verdict in High-Stakes Qualcomm-ARM Licensing Battle" (Stocktwits) - "Why Arm Holdings Stock Was Falling Today" (Motley Fool) - "How Qualcomm's Legal Win Over Arm Could Reshape the Long-Term Thesis for QCOM Investors" (Simply Wall St.) - "Arm Holdings Has a $4.9 Billion Business Model on Trial. Here's What It Means for ARM Stock." (Barchart) - "AI Is Blowing Up Tech's Money Rules. How Arm Could Make Qualcomm Pay More." (Barchart)

Conflicting headline: TIKR ran "Qualcomm and Arm Trial Ends in Hung Jury Over Licensing Breach Allegations." - I can't tell whether this is the same trial or an earlier or separate phase. - From my own background knowledge (not these tools), a prior Delaware trial in late 2024 also had a partial hung-jury result. - Treat the exact scope of the verdict and any remaining claims, appeals, or retrial as unverified. Confirm the details before sizing a position.

What it means for ARM: - Direction: The headlines say the market read the outcome as negative for ARM, and the stock fell. - Thesis risk: The Barchart "$4.9B business model on trial" framing suggests the case bears on how much Arm can charge licensees and on its royalty-uplift strategy. A loss weakens the narrative that Arm can push higher royalty rates on big licensees. - Counterpoint: The "make Qualcomm pay more" article suggests some commentators think Arm still has leverage as AI raises the value of its IP. I can't verify that from headlines alone.

Other ARM items: - Options: Barchart reported "Heavy Unusual Call Option Activity in Chip Designer Arm Holdings." Some traders are positioning for upside or a rebound. The headline doesn't say which strikes or expiries, or whether the activity came before or after the verdict. - Sentiment and awards: Insider Monkey ran several positive "AI/specialized computing" pieces, and Simply Wall St. covered an AI ecosystem award. These are low-signal. - Peer comparison: Motley Fool's "Arm vs. Sandisk" shows retail interest in ARM as an AI-adjacent name. - Earnings: No ARM earnings date appeared in the results. From general knowledge, Arm's fiscal Q2 report usually lands in late October or early November. Verify the date.

2. Global and macro backdrop (headlines and prediction markets)¶

Rates and inflation: hawkish and a headwind for long-duration tech. - Yahoo Finance: "10-year Treasury yield rises following hot inflation data." - Yahoo Finance: "Bond yields are surging worldwide — and France is on the 'ugly side'." Global duration selling is happening. - Yahoo Finance: mortgage rates are at a near three-year high, with "Is 8% next?" commentary. - A BofA fund-manager survey headline says managers won't rotate from stocks to bonds until yields hit about 5.9%. Equity holders are tolerating high yields, so there is room for further valuation pressure if yields keep rising.

Fed path from Polymarket (hawkish): - "No Fed rate cuts in 2026": 97% ($8.9M volume, +1.1pp on the week). - "Another Fed rate hike in 2026": 86% (+8.0pp on the week, resolves 2026-12-10). - Hike-count markets: 1 hike 14% (−7pp), 2 hikes 64%, 3 hikes 20% (+9.8pp), 4 hikes 1%. - The word "another" suggests the Fed has already hiked this year. The distribution is consistent with that: P(2+ total) is about 85%, close to the 86% above. That is my inference, so verify it. - The mix shifted toward more hikes this week. A tightening bias is the dominant macro risk for high-multiple semis like ARM.

Recession odds are low. Polymarket gives 8% for a US recession by end-2026 (+1.0pp on the week). The market is pricing a stagflation-lite or "higher for longer" regime, not a hard landing.

Energy and geopolitics: - Yahoo Finance: "Oil falls to $103 as Trump says US will not attack Iran before the midterm elections." Oil is above $100. - Yahoo Finance: "Tech slumps as oil prices rise, focus turns to earnings season kickoff." Oil strength has been hitting tech. - Polymarket "US invades Iran before 2027": 16% ($74M volume, +1pp). This is a material tail risk that feeds oil and inflation. - China–Taiwan risk is low in the near term: invasion by end-2026 is 2%, a military clash before 2027 is 4%, and a blockade in 2026 is 3%. The 2027 invasion odds are 10% by December 2027. This matters for the semiconductor supply chain, since Arm's licensees depend on TSMC.

Equity-market tone: fragile, with rotation out of chips. - Yahoo Finance: "Bank stocks rise on JPMorgan, Goldman earnings as chip stocks fall." Money rotated from semis to financials. - Yahoo Finance: "Why BlackRock is suddenly more bearish on stocks." - Yahoo Finance: "Bubble-like stock valuations and debt crisis chatter aren't exactly bullish." - Yahoo Finance: "Tech rebounds as AI trade jitters ease." There is two-way volatility in the AI trade. - Polymarket gives 68% that the S&P 500 is 2026's best-performing major asset (+3pp), so the broad equity bull narrative is still intact.

3. Trading implications for ARM (evidence only; the trade decision is for the next agent)¶

Litigation overhang plus a hawkish macro backdrop. Company-specific negative news landed while yields were rising, oil was above $100, and chips were being sold. These factors compound for a high-multiple, long-duration name.
Event risk to track:
Post-trial motions, appeals, and any retrial on the hung-jury portion.
ARM's fiscal Q2 earnings, for royalty-rate commentary and the licensing-versus-royalty mix.
The next CPI and PCE prints and FOMC communications. A hot print raises the odds of more hikes.
Q3 earnings from the large AI and semiconductor names, which set sector sentiment.
Iran headlines, which move oil, inflation expectations, and risk appetite.
Options signal is mixed. Unusual call activity suggests some buy-the-dip positioning. Without strike, expiry, and timing data, it isn't a reliable bullish signal.
Tail risks:
Iran escalation (16% by 2027).
A bond-market accident, given the global yield surge and the debt-crisis chatter.
An AI-valuation unwind, as flagged by the BlackRock and "bubble" headlines.
Taiwan risk is low near-term but large in impact.
Possible upside catalysts:
Rates stabilizing or inflation cooling.
A narrow or appealable verdict that leaves Arm's licensing model intact.
Continued AI and data-center Arm-architecture adoption.
A rebound in the "AI trade jitters ease" mode.

Summary table¶

Category	Key point	Evidence / source	Implication for ARM
Litigation	Jury ruled for Qualcomm in the Delaware licensing dispute; ARM shares fell	Investing.com, Stocktwits, Motley Fool, Simply Wall St.	Negative. Pressure on the royalty-uplift and licensing-power thesis
Litigation (conflict)	A TIKR headline says "hung jury"	TIKR	The scope of the verdict is unclear (possible earlier or partial phase). Verify before acting
Business model	"$4.9B business model on trial"; Arm may still have leverage over Qualcomm	Barchart	The case bears on future licensing economics
Options	Heavy unusual call activity in ARM	Barchart	Some dip-buying or upside positioning. Strikes and timing unknown
Fed path	No cuts in 2026: 97%. Another hike in 2026: 86% (+8pp w/w). 2 hikes: 64%, 3 hikes: 20%	Polymarket	Hawkish. A headwind for long-duration growth and semis
Rates / inflation	10Y yield up on hot inflation; global yields surging; mortgage rates near 3-year high	Yahoo Finance	Valuation pressure on high-multiple tech
Growth	US recession by end-2026: 8%	Polymarket	Low recession odds. Risk is higher-for-longer, not a collapse
Energy / geopolitics	Oil about $103; US invades Iran before 2027: 16%	Yahoo Finance, Polymarket	Inflation and risk-off tail. Oil strength has coincided with tech weakness
Taiwan	Invasion by end-2026: 2%; clash: 4%; by Dec 2027: 10%	Polymarket	Low near-term odds, but a supply-chain tail risk (TSMC)
Equity tone	Chips sold while banks rallied; BlackRock more bearish; bubble talk; "AI jitters ease" at times	Yahoo Finance	Choppy, two-way AI trade. Sector rotation risk
Macro data (FRED)	Unavailable (API key missing)	Tool error	No hard CPI, unemployment, VIX, or yield-curve numbers. Fetch them before relying on macro conclusions
Upcoming catalysts	ARM earnings (date unverified), CPI/PCE, FOMC, big-tech earnings, litigation follow-ups, Iran news	Inferred	Plan for event-driven volatility

Fundamentals Analyst¶

ARM (Arm Holdings plc) Fundamental Report¶

Data as of 2026-10-14. Sector: Technology / Semiconductors. Exchange: NMS. Fiscal year ends March 31, so the quarter ended 2026-06-30 is fiscal Q1 FY27.

The tools returned no filings or insider activity from the past week. The latest financials are the June 30, 2026 quarter, and the latest insider transaction is 2026-09-21. Figures marked "derived" are my own arithmetic on the tool output, not reported numbers.

1. Snapshot and Valuation¶

Metric	Value
Market cap	~$254.2B
Implied share price	~$238 (derived: P/E 245.4 × EPS 0.97, and P/B 29.45 × book value 8.081, both give ~$238)
P/E (TTM) / Forward P/E	245.4x / 77.7x
PEG	2.1
Price/Book	29.5x
Price/Sales (derived)	~49x
EV/EBITDA (derived, roughly market cap / EBITDA)	~240x
EPS (TTM) / Forward EPS	$0.97 / $3.06
Beta	3.79
52-week range	$100.02 – $452.70
50-day / 200-day average	$270.50 / $221.55
Dividend yield	0%

The stock has fallen sharply from its high. The implied price is about 47% below the 52-week high and about 138% above the low. It is about 12% below the 50-day average and about 7% above the 200-day average.
The CFO sold at $300 on 2026-09-21. If the implied ~$238 is right, the stock has fallen roughly 20% in about three weeks. That is inferred, not directly observed.
The valuation prices in a large earnings ramp. Forward EPS of $3.06 is about 3.2x TTM EPS of $0.97. The latest quarter's GAAP EPS was $0.25, which annualizes to about $1.00. The forward figure is probably an analyst-consensus number on a different (likely non-GAAP) basis than the GAAP TTM figure. The tool does not say, so treat the 77.7x forward P/E with caution.
Beta of 3.79 means very large swings in both directions. That fits the $100 to $453 range in one year.

2. Profitability and Returns¶

Revenue (TTM): $5.156B. Gross profit: $5.029B, a gross margin of about 97.5%.
EBITDA: $1.064B (about 20.6% margin). Net income: $1.044B (20.2% margin). Operating margin: 7.6%.
ROE: 13.4%. ROA: 5.4%.
Earnings quality flag. TTM net income ($1.044B) is almost equal to EBITDA ($1.064B), and the net margin (20%) is much higher than the operating margin (7.6%). In the latest quarter, net income was $270M against operating income of only $91M. Interest income on about $3B of cash would not explain that gap by itself. Tax benefits or other non-operating items probably contributed. The tools don't break this out, so the next filing needs checking.

3. Income Statement Trend (USD millions, quarterly)¶

Quarter	Revenue	Gross Profit	Op. Income	Op. Margin (derived)	Net Income	Diluted EPS
Jun-2024	939	906	182	19.4%	223	0.21
Sep-2024	844	812	64	7.6%	107	0.10
Dec-2024	983	955	175	17.8%	252	0.24
Jun-2025	1,053	1,023	114	10.8%	130	0.12
Sep-2025	1,135	1,106	163	14.4%	238	0.22
Dec-2025	1,242	1,212	185	14.9%	223	0.21
Jun-2026	1,289	1,253	91	7.1%	270	0.25

The feed omits the March quarters and some others.

Revenue growth is solid. Year-over-year growth was +12% (Jun-25), +34% (Sep-25), +26% (Dec-25) and +22% (Jun-26, derived).
Operating costs are growing faster than revenue. Operating expenses (gross profit minus operating income, derived) were about $724M in Jun-24, $909M in Jun-25 and $1,162M in Jun-26. That is roughly +26% and +28% year over year, against revenue growth of about 22% in the latest quarter.
Operating income fell as revenue rose. In Jun-26 it dropped about 20% year over year ($91M vs. $114M), and the operating margin of 7.1% is the lowest in this window outside the Sep-23 loss.
Net income and EPS roughly doubled year over year ($270M vs. $130M; $0.25 vs. $0.12). Given the operating income trend, this is a below-the-line effect rather than operating leverage.
Implied March-2026 quarter (derived). TTM revenue of $5,156M minus the three reported quarters gives about $1,490M. TTM net income gives about $313M for that quarter. If that holds, Jun-26 revenue fell about 13% from the prior quarter. That may be seasonal or tied to licensing timing, but the feed can't confirm it.
Cost of revenue is negligible at $36M (about 2.8% of revenue), which is typical of an IP-licensing model.

4. Balance Sheet (USD millions, as of 2026-06-30)¶

Item	Jun-26	Mar-26	Mar-25
Total assets	11,196	10,703	8,932
Current assets	6,339	6,236	4,830
Cash & equivalents	3,058	2,751	2,085
Total liabilities	2,566	2,417	2,093
Current liabilities	1,207	1,040	929
Stockholders' equity	8,630	8,286	6,839

Liquidity is very strong. The current ratio is 5.25 (6,339 / 1,207), and cash is up about 47% from Mar-25.
Leverage is minimal. Debt-to-equity is 5.6%, which is roughly $485M of debt (derived). Equity is about 77% of total assets, so the company holds net cash.
Equity grew about 26% from Mar-25 to Jun-26.
Current liabilities are up about 16% from March to June. Without detail, this could be deferred revenue, payables or accruals.
The price multiples are far above book value. At 29.5x book, the valuation rests on future growth rather than asset backing.

5. Cash Flow (USD millions; the feed reports year-to-date cumulative figures)¶

Period (fiscal YTD)	Operating CF	Capex	FCF (derived)	Investing CF	Financing CF
Q1 FY26 (Jun-25, 3M)	332	154	178	-372	-123
H1 FY26 (Sep-25, 6M)	899	292	607	-176	-313
9M FY26 (Dec-25)	1,264	471	793	-124	-443
Q1 FY27 (Jun-26, 3M)	902	197	705	-267	-326

Operating cash flow was very strong in Q1 FY27. It was $902M against net income of $270M, and up about 172% from $332M a year earlier. Free cash flow was about $705M for the quarter. Cash flow is lumpy, driven by licensing and royalty billing timing and working capital, so I wouldn't extrapolate one quarter.
The reported TTM free cash flow is $1.33B. My quarterly pieces (Q2 FY26, Q3 FY26 and Q1 FY27) sum to about $1.32B. That would leave almost nothing for the March quarter, which suggests either a weak Q4 FY26 or a different FCF definition. The March-quarter cash flow isn't in the feed, so I can't resolve it.
Capex is rising. It runs about $140–200M per quarter, roughly 15% of revenue, up from the $26–82M range in earlier years. The tools don't say what it funds.
Financing outflows are growing. Q1 FY27 outflow was $326M, about 2.6x the prior-year quarter. The cause isn't specified. Common causes are tax withholding on equity awards or buybacks, but the data doesn't say.
The cash reconciliation checks out. The $307M cash increase in the quarter matches 902 − 267 − 326 = $309M.

6. Insider Transactions (Mar–Sep 2026)¶

The feed shows no open-market insider purchases, only sales, grants and gifts.

Insider	Role	Sales (shares)	Approx. proceeds (derived)	Price range
Jason Child	CFO	95,280 (5 sales)	~$20.0M	$148 → $300
Spencer Collins	Officer	92,902 (2 sales)	~$19.8M	$208–$215
William Abbey	Officer	43,831 (6 sales)	~$12.0M	$199 → ~$400
Rene Haas	CEO	41,152 (2 sales)	~$6.6M	~$160–163
Richard Grisenthwaite	Officer	24,339	~$5.1M	~$209
Laura Bartels	Officer	11,306	~$4.4M	~$393
Charlotte Eaton	Officer	14,905 (2 sales)	~$4.2M	~$252–291
Total			~$72M

Timing. Most sales cluster between 2026-05-11 and 2026-06-02, right after the 2026-05-15 equity grants. The CEO's most recent sales were in March and April. He received a 265,643-share award on 5/15.
CFO's recent sales. The CFO sold again on 2026-08-27 (10,400 shares at $255.33) and 2026-09-21 (10,400 shares at $300.00). The repeated 21,280-share and 10,400-share lot sizes at round prices look like a pre-set schedule, but the feed doesn't say whether these were 10b5-1 plan sales.
Grants. Large grants on 2026-05-15 went to the CEO (265,643 shares), the CFO (81,359), Collins (69,117), Abbey (23,310), Grisenthwaite (22,690) and Eaton (5,612). Directors had unpriced entries of 2,141 shares each. Director Jeffrey Sine gifted 9,572 shares on 2026-08-07.
Interpretation. Selling this heavy is not unusual after grants and a big rally, and the absence of buying is a neutral-to-mildly-negative signal. Insiders sold into strength, with several sales between $300 and $415 before the pullback. No insider bought after the stock fell to around $238.

7. Key Considerations for Traders¶

Supportive factors - Revenue is growing at a 20%+ year-over-year rate, with a gross margin near 97%. - The balance sheet is very strong, with $3.1B of cash, a 5.25 current ratio and minimal debt. - Operating cash flow and FCF are strong and rising (TTM FCF is $1.33B). - The stock has pulled back sharply from its high, to near the 200-day average.

Risk factors - The valuation is extreme: 245x trailing earnings, ~49x sales and 29.5x book. The forward P/E of 77.7x depends on EPS tripling. - Operating margin is compressing because operating expenses are growing faster than revenue. Q1 FY27 operating income fell about 20% year over year despite 22% revenue growth. - GAAP net income is well above operating income, so earnings quality needs checking. - Capex is climbing, and financing outflows are growing for reasons the data doesn't show. - Beta is 3.79, and the stock has a $100–$453 range. - Insider selling totaled about $72M and there were no purchases.

What to watch - The fiscal Q2 FY27 report (quarter ended 2026-09-30). Based on last year's timing it is likely in early November, but that date comes from my recollection, not the tools. - Whether operating expenses grow slower than revenue, and what drives the gap between net and operating income. - Whether the strong Q1 operating cash flow persists, and what capex and the financing outflows are funding. - Further insider filings, particularly any purchases.

8. Data Caveats¶

The quarterly income statement and cash flow feeds skip some periods, including the March quarters. The implied March-quarter numbers are derived and unverified.
Cash flow data is cumulative within each fiscal year.
The forward EPS basis (GAAP or non-GAAP) isn't specified.
The share price is inferred from valuation ratios, not quoted directly.

Summary Table¶

Category	Key Data Point	Takeaway
Valuation	P/E 245x, forward P/E 77.7x, P/S ~49x, P/B 29.5x, PEG 2.1	Priced for a large earnings ramp
Implied price	~$238 vs. 52-week range $100–$453	~47% below the high, near the 200-day average ($221.5)
Revenue	TTM $5.16B; Jun-26 quarter $1,289M (+22% YoY)	Strong, steady growth
Gross margin	~97.5%	Asset-light licensing model
Operating income	Jun-26 quarter $91M (7.1% margin), down ~20% YoY	Operating expenses (+~28% YoY) outpacing revenue
Net income / EPS	Jun-26 quarter $270M / $0.25, roughly double YoY	Gap vs. operating income points to non-operating or tax effects; verify
Balance sheet	Cash $3.06B, current ratio 5.25, debt/equity 5.6%	Very strong liquidity, net cash
Equity	$8.63B (up ~26% since Mar-25)	Growing book value; stock at 29.5x book
Operating cash flow	Q1 FY27 $902M (vs. $332M a year ago)	Strong but lumpy
Free cash flow	TTM $1.33B; Q1 FY27 ~$705M (derived)	Healthy; Q4 FY26 appears weak or definitions differ
Capex	~$197M in Q1 FY27 (~15% of revenue)	Rising; purpose not specified
Financing cash flow	-$326M in Q1 FY27 (vs. -$123M)	Growing outflow; cause not specified
Insider activity	~$72M of sales, 0 open-market purchases (Mar–Sep 2026)	Selling after the rally and grants; no insider buying on the pullback
CFO (Child)	~$20M sold; latest 10,400 shares at $300 on 2026-09-21	Regular-looking cadence; sold well above the implied current price
CEO (Haas)	~$6.6M sold in Mar–Apr; 265,643-share grant on 5/15	No sales since April
Risk	Beta 3.79, margin compression, extreme multiples	High volatility
Next catalyst	Fiscal Q2 FY27 earnings (likely early November; not from the tools)	Check operating expense trend, earnings quality and cash conversion

II. Research Team Decision¶

Bull Researcher¶

Bull Analyst: # Bull Case for ARM: A Quality Franchise at a Reset Price

Since the bear hasn't spoken yet, I'll make my case and then take on the objections I expect.

1. The market has erased the froth, not the franchise¶

At $238.01, ARM has given back its entire September spike. It is below the pre-spike close of $243.98 on 09-16. It is also about 46% below the June 18 peak close of $439.46 and about 29% below the 09-22 close of $333.20.

The business didn't deteriorate by 46% in four months. Revenue for the June quarter was $1,289M, up about 22% year over year, with a 97.5% gross margin. That is a licensing model where nearly every incremental dollar of revenue is gross profit. The stock fell on multiple compression, rates, a sector rotation, and a court verdict. Those are valuation and sentiment shocks, not a broken growth engine.

2. Cash generation is real¶

Operating cash flow was $902M in the June quarter, against $332M a year earlier (+172%). Free cash flow was about $705M, and TTM FCF is $1.33B.
The balance sheet is a fortress. Cash is $3.06B, the current ratio is 5.25, and debt-to-equity is 5.6%. Equity is up about 26% since March 2025.
A net-cash company with this margin structure can fund its own investment cycle. Rising capex and R&D don't threaten solvency or require dilution.

Cash flow is lumpy and I wouldn't extrapolate one quarter. Still, it shows the business converts revenue to cash, which the bears can't wave away.

3. The verdict reaction looks oversized relative to what we know¶

The headlines read "jury rules in favor of Qualcomm." But the Arm statement quoted on StockTwits says the jury found for Arm on four claims and awarded only $1 on each of Qualcomm's other two. A TIKR headline separately says "hung jury." I can't reconcile these from headlines, and the scope of any remaining claims or appeals is unverified. Even so, nothing in the evidence points to a material financial penalty.

The price action also gives me two reasons for perspective:

Today's drop was about -6.8%, less than one ATR (17.28, or 7.3% of price). That is a normal day for a stock with a 3.79 beta.
Most of the slide came before the verdict. The close went from $307.49 on 10-02 to $255.39 on 10-13, about -17%, and the verdict-day drop was a further ~7%. I'm inferring the verdict timing from the StockTwits message window, so treat it as approximate. Over the same stretch, the macro tape was hostile: chips sold while banks rallied, oil was above $100, and yields surged.

The legal risk that matters is precedent for Arm's royalty-uplift strategy, and I'll address it below. The verdict itself looks more like a catalyst for a sector selloff than the cause of one.

4. Risk/reward from here¶

Reference	Level	Distance from $238.01
200 SMA (rising)	222.19	about -6.6%
Monthly SuperTrend stop (regime invalidation)	198.17	about -16.7%
10 EMA / 50 SMA cluster	~270	about +13.5%
Daily SuperTrend stop	295.73	about +24%
09-22 close	333.20	about +40%

Several indicators say the sell-off is stretched on the short timeframe:

Price is on the lower Bollinger band (238.05).
The daily z-score is -2.00.
RSI is 35.87, the lowest in the window.
The monthly SuperTrend is still UP.

The 219–226 zone, which holds the 200 SMA and the 07-29, 08-03 and 09-03 lows, was followed by higher closes the next session all three times. That is only three observations and I won't oversell it. But the 200 SMA has risen every session in the window, and the invalidation line is clear.

5. Preempting the bear¶

"245x trailing earnings is absurd." I won't pretend ARM is cheap. At 77.7x forward EPS of $3.06, the multiple assumes a big earnings ramp. But the stock is already 46% off its high, so a lot of that excess has been squeezed out. The forward-EPS basis may be non-GAAP, and I'll flag that myself. The question is whether 20%+ growth at 97% gross margins deserves a premium, and I think it does.

"Operating margin is compressing." This is the bear's best fundamental point. Operating income was $91M (7.1% margin) against $114M a year ago, and opex grew about 28% against 22% revenue growth. I read that as an investment phase, and the rising capex fits. But it only works if revenue growth eventually outruns cost growth, and the November report is where it gets tested. The gap between net income ($270M) and operating income ($91M) also needs explaining from the filing. I won't claim to know what drives it.

"Insiders have sold $72M and haven't bought." The sales cluster in May and June after the 05-15 grants, and many were at far lower prices than today's. The CFO's repeated 10,400-share lots at round prices look scheduled, though I can't confirm 10b5-1 status. The $72M is under 0.03% of the $254B market cap. The lack of insider buying is a fair observation, but it is not a thesis breaker.

"The weekly trend is down and MACD is still falling." True. The weekly SuperTrend is DOWN and the MACD histogram has made new lows eight sessions running. That argues for scaling in rather than going all-in at once. It doesn't argue against the multi-month case.

"Macro is hostile." The Polymarket odds put the chance of another Fed hike at 86%, with no cuts in 2026 at 97%. But a hike path priced at those odds is largely in the price. Recession odds are only 8%, so the demand picture isn't breaking, and the S&P is still 68% likely to be 2026's best major asset. With a beta of 3.79, any stabilization in yields would work strongly in ARM's favor.

6. Where I'm cautious¶

I'm not calling the exact bottom. The tape is bearish, today's bar may be partial, and the verdict scope is unverified. Sentiment is only a weak supporting signal: it's low-confidence, about one day of data, and the 12:2 bullish skew rests on about nine unique bullish authors. The unusual call activity is encouraging, but I have no strike or expiry detail.

My plan is to build the position in tranches around the 222–238 area. If the monthly SuperTrend at 198 breaks, I'm wrong.

7. What I'm watching¶

Fiscal Q2 earnings, likely early November (not tool-verified): does opex growth slow, and does cash conversion hold?
Post-trial motions and appeals: does the verdict constrain Arm's royalty rates?
CPI/PCE and FOMC: do yields stabilize?

My challenge to the bear¶

You'll point to valuation, margin compression, and the broken trend. Those are fair. But tell me why a net-cash, 97%-gross-margin business growing revenue over 20% and generating $1.33B in annual FCF deserves to stay down 46% from its high on a verdict with $1 in damages. The question isn't whether the stock was overvalued at $439. It's whether it is mispriced at $238. Bull Analyst: # Bull Rebuttal: Conceding What's Fair, Defending What Matters

You landed real punches, so I'll take those first. Then I'll show where your case leans harder than the evidence allows. Figures marked "derived" are my arithmetic on the tool outputs. Today's bar may still be partial.

Where you're right¶

ATR. The drop was 17.38 points against an ATR of 17.28, and I mixed percentage bases. The verdict-day move was exactly one ATR, not "less than one." I still draw the same inference: a typical-sized day for this stock is not a market declaring the thesis dead. But I won't claim "less than."
Precedent. I promised to address it and didn't. That's below.
Beta. It cuts both ways. I'm sizing for the downside side of it.
Technicals. The weekly z-score is -1.05, the monthly is +0.70, RSI is above 30, and the 200 SMA's rise is partly mechanical. I'm not calling a washout. The weekly SuperTrend is DOWN and the MACD histogram has fallen eight straight sessions, so I won't fade that at full size.
Cash flow. I never said run-rate, and I won't defend TTM FCF of $1.33B as one. My reconciliation also showed a near-zero implied March quarter. That is either a timing reversal, which would be your point, or a different FCF definition. Neither of us can resolve it.
Sentiment. I'll drop it. Fourteen tagged posts from about nine bullish authors over one day is not a signal in either direction. That includes your "contrarian warning."
Insiders. The absence of buying is a mild negative.

The verdict: precedent, finally¶

What was decided. Of your "three independent outlets," Investing.com and Simply Wall St. framed it as a Qualcomm win. Motley Fool's "Why Arm Holdings Stock Was Falling Today" is a price-move headline, not a verdict reading. On Arm's own characterization, Qualcomm won liability on two claims and the jury valued each at $1. That is a mixed result with essentially no damages, and I'm not calling it an Arm victory.

The retrial leg. Your retrial argument rests on one TIKR headline. The news report notes, from background knowledge rather than a tool, that a late-2024 Delaware trial in this dispute also ended partly hung. That headline may be stale. We can't tell, so retrial can't carry weight.

Precedent. This is my reasoning, not a tool output, and I'm not a lawyer. A jury verdict construes the specific contracts between Arm and Qualcomm. It doesn't bind how Arm prices a different licensee's new deal. Only appellate legal rulings carry beyond the parties, and those still turn on contract language. The real channel is commercial: other licensees can cite the result at the negotiating table. That channel is observable in royalty and licensing revenue, and June-quarter revenue grew 22% with this litigation live. Barchart's "$4.9 billion business model on trial" is also just a headline, and neither of us has the article. The evidence that would settle this is post-trial rulings and royalty commentary on the next two prints.

Margins and the forward-EPS math¶

Your June-quarter table is three points from one quarter a year. The full reported operating margin series is 19.4%, 7.6%, 17.8%, 10.8%, 14.4%, 14.9%, 7.1%. A 7.1% quarter isn't new, since Sep-24 was 7.6% and was followed by 17.8%. That doesn't prove leverage is coming, and the November print is the test. The May 15 grants also fall inside the June quarter. How much of the 28% opex growth is stock comp versus hiring is a 10-Q question I can't answer.

On the 52% net margin. You said a non-GAAP basis "only means the real bar is higher." That's true for valuation, because GAAP P/E is above 77.7x. It's backwards for feasibility. Non-GAAP excludes items like stock comp, so comparing it to a GAAP net margin overstates the leap. The period is also unspecified and could be beyond 12 months.

I can't prove $3.06, so I don't underwrite it. What I underwrite is convexity. Using the June-quarter run rate (derived, illustrative, not a forecast):

Next-12-month opex growth (revenue +22%)	Operating income	Operating margin
+22% (no leverage)	~$443M	~7.0%
+15%	~$769M	~12.2%
+10%	~$1,001M	~15.9%

The run-rate baseline is about $364M. Each point of opex growth is worth about $46M of operating income, so one line item swings earnings power more than anything on the tape. Even the 10% case is ~$1.0B of operating income against a $254B market cap. I'm not saying that's cheap. I'm saying it's a long-duration option on that line item, and it reports in roughly three weeks (early November, unverified).

On the balance sheet. I used $3.06B of cash to show the company funds itself, not to support the valuation. Cash is up 47% since March 2025 while capex runs ~15% of revenue.

Insiders, macro, and your $153¶

Insiders. Using the table's ranges (derived), about $46M of the $72M was sold below today's price. About $14M was sold above it (Bartels, Eaton, the CFO's last two lots), and Abbey's $12M straddles. Nobody bought at $148–$215, and the stock then ran to $439, so insider silence has been a poor timing signal on this tape. RSU-compensated executives also rarely buy in the open market, though that base rate is general knowledge, not from the tools.

Macro. Duration is the risk. But the hike odds moved +8pp from a base where two or more hikes were already ~78% likely. That explains direction, not a 22.6% drop in eight sessions. A 3.79 beta, sector rotation and the verdict explain the magnitude better.

Your $153. That figure is 50x forward EPS. The 50x is your choice, and its landing near April's $159 close is a coincidence, since April's forward EPS was a different number. To reach $153, price must break the 219–226 cluster, the 200 SMA and the 198 monthly line. That is my invalidation. We agree on the map, and we differ on whether to pay for the option before the print.

My plan, with the geometry stated honestly¶

My stop-versus-target geometry is not an edge. A 198 stop is 16.7% away and the 295.73 daily SuperTrend flip is 24.3% away (derived). That needs a ~41% hit rate to break even, which is roughly what a driftless walk gives. Any edge has to come from the opex convexity, not from chart levels.

So I'm not averaging into a falling name. The structure is:

Starter (about one-third of target size) now.
Second third only on a retest of 219–226 that closes back above 226.
Final third on a daily close above ~255 with the MACD histogram turning up. That overlaps your own change-my-mind list.
Sizing: a full stop-out costs about 1% of capital, and a 25% gap through the stop costs about 1.5%.

What proves me wrong: - A close below 198.17. - September-quarter opex growing faster than revenue again, or revenue growth falling to the mid-teens. - A post-trial ruling or filing that explicitly limits royalty uplift with other licensees. - A 10-Q showing the net-over-operating income gap is mostly one-time.

We agree this is a great business at a rich price in a primary downtrend. Our real disagreement is narrower: do you pay a small, defined price now for the option on the November opex line, or a higher price after it prints? I think that one line moves the stock more than the tape, the Fed odds or the verdict, and I'd rather own a starter position going in. Bull Analyst: # Bull Closing: Conceding the Ledger, Then Isolating the Question That Decides It

"Derived" marks my arithmetic on the tool outputs. Today's bar may still be partial.

What I'm giving up¶

The +28% row. It's the observed trend and it belongs in my table. It takes run-rate operating income to about $165M. That is the downside case, and I won't argue it away.
"One line moves the stock more than the tape." Retracted. Your sizing (about $836M × 35x ≈ $29B, roughly 11% of market cap, derived) is fair. It's real, about 1.5 ATRs, and not dominant. "Option" was loose language. I mean a defined-loss position with a fat right tail, not a $254B premium.
Verdict timing. The September quarter predates the verdict, so November can't show any commercial effect. I agree.
Checkable gates. The net-over-operating gap and Qualcomm's share of revenue can be answered from filings today. They now sit in front of my second tranche, not behind the print.
A new one against myself.
September 2025 opex was $943M (1,106 − 163) and June 2026 was $1,162M. Holding opex growth to 22% year over year in September would need opex to fall about 1% sequentially (derived).
June-to-September opex rose 3.3% and 3.7% in the last two years (derived). At +3.5%, September opex is about $1.20B and operating income about $140M against $163M a year ago. That is the same illustration you gave.
So "opex growth below revenue growth" is a mechanically harsh test. The better one is sequential: opex growth under about 2% puts operating income above $163M at +22% revenue.
Expect an ugly year-over-year headline unless that happens. Neither of us has consensus, so neither of us knows how the stock will read it.

The question that decides it is drift¶

Your strongest practical point is the cost of being early (−16.7% to 198) against the cost of waiting (+7.1% to 255). Those costs need probabilities. In the driftless walk you used to dismiss my stop-and-target geometry, the chance of touching 255 before 198 is (238.01 − 198.17) / (255 − 198.17) ≈ 70% (derived). That equals the break-even implied by your own cost ratio, 16.7 / (16.7 + 7.1). On your assumption, starting now and waiting are a wash.

So the stops, tranches and "information costs" language don't decide this. The question is whether expected return from here is positive or negative.

Your side: negative momentum. The weekly SuperTrend is down, the MACD histogram is at new lows, and the TD count has room to run. That's a legitimate argument.
My side: I have no chart edge, as I conceded. What I have is franchise economics.
In the June quarter, gross profit rose $230M on $236M of added revenue, a 97.5% incremental gross margin.
Opex rose $253M, so operating income fell $23M.
The margin problem sits entirely in a discretionary cost line. It is not in pricing power or gross margin.
The company has $902M of quarterly operating cash flow and about $2.6B of net cash (derived), so it funds any correction itself.
None of that is valuation support. It means an opex mistake is fixable, which makes the left tail less likely to be permanent.

Confirmation has been the worse price, twice¶

Your re-entry is a close above 255 with a MACD histogram turn. The tool data has two episodes where a "strength" entry followed a low. I haven't verified the histogram on those dates. These are two observations picked after the fact, which is the same thinness I conceded on the 219–226 bounces. The report's list of 15%+ days also omits 08-04, so check that bar before leaning on it.

Episode	Buy at the low	Buy on strength	Marked at	Low-buyer vs. strength-buyer
Aug	239.06 (08-03)	280.56 (08-04)	234.82 (09-01)	−1.8% vs. −16.3%
Sep	243.98 (09-16)	275.61 (09-18)	238.01 (today)	−2.4% vs. −13.6%

In a stock that can move 17% in a session, waiting costs more than "7%," and so does the confirmation price. The same critique hits my third tranche. That's why I treat it as a sizing rule, not an edge. If the 219–226 zone and the 200 SMA break, this evidence flips, so I'm not relying on it.

Macro: unmeasured, not absent¶

On the quoted changes (1-hike −7pp, 3-hike +9.8pp, the offset assumed to sit in the 2-hike bucket), the expected 2026 hike count rose by about 0.17. That is roughly 4bp of extra tightening at 25bp per hike (derived, assumption-heavy). It's too small to explain a 22.6% fall by itself. But the 10Y and term premium matter more for duration than hike counts, and FRED failed. So I can't call yields stabilizing, and you can't call macro dominant. My plan doesn't assume stabilization. The 198 line covers the case where yields keep rising.

Plan, revised¶

Starter: about one-third of target size now. On my earlier sizing, a stop-out at 198.17 costs about 0.3% of capital, or about 0.5% through a 25% gap (derived).
Second third: a retest of 219–226 that reclaims 226, plus a filing read showing the net-over-operating gap is explained and what share of revenue Qualcomm represents.
Final third: either September opex growth under about 2% sequentially, or a close above 255 with the MACD histogram turning. Either one gets small size.

Proves me wrong: - A close below 198.17. - September sequential opex growth at or above about 3.5% with revenue growth in the mid-teens or lower. - A filing showing the net-over-operating gap is one-time. - A ruling or filing that limits royalty uplift, or a Qualcomm revenue share that is large and at risk.

Where this leaves us¶

We agree on the facts: a great business at a rich price in a primary downtrend, with a verdict that can't be bounded before February. Your two remaining reasons to wait are:

Negative drift. That's a momentum call in a stock whose last two strength entries lost 13–16%.
The unresolved verdict. By your own timing argument, waiting for November doesn't resolve it.

My ask is small. Give the franchise a position that risks about 0.3% of capital to take part in the next gap, then add only when the filings and the 219–226 zone earn it. If you believe drift from here is negative, wait. The 70% math says that's the only reason to. Bull Analyst: # Bull Close: Filings First, a Sell Rule, and the Print Is Not a Gate

"Derived" means my arithmetic on the tool outputs. Today's bar may still be partial.

What I'm giving up¶

Filings go in front of the starter. Your logic holds. If the net-over-operating gap, the stock-comp share of opex and Qualcomm's revenue share are material enough to gate tranche 2, they gate tranche 1. They cost an afternoon, not a price, so they move to step zero.
A sell rule. You're right that the money in both episodes was in selling the gap days. My plan had a stop and no exit short of 295.73. The fix is below.
The table isn't drift evidence. The 08-03 low-buyer is at −0.4% (derived). I'll cite the episodes only for the shape of the range (225–333 in ten weeks), not as a claim about drift.
The "six tests." Repeated-test folklore cuts both ways. I won't call the 235–244 band support, and you shouldn't call it a weakening level.
"Fixable." That was too loose, because stock comp is sticky. The narrower claim I can defend is that the margin problem sits below gross profit, not in pricing power. How sticky it is depends on the 10-Q, so stock comp joins the gates.

Where your close still overreaches¶

1. The print is a coin flip on operating income, and neither of us can call it¶

We agree on the base-case row, but your +6.4% row isn't a seasonal analog. It averages the Dec→Jun steps, which include the fiscal-year-start step-up (the 05-15 grants fall inside the June quarter, which is an inference). The like-for-like June→September opex steps were +3.3% (2024) and +3.7% (2025) (derived). I read your −33% row as a stress case.

At +3.5% sequential opex, each point of revenue growth is worth about $11M of operating income (derived):

Sep-26 revenue growth	Revenue ($M)	Operating income ($M)	vs. $163M
+18%	1,339	~99	−39%
+22%	1,385	~143	−12%
+24%	1,407	~165	+1%
+26%	1,430	~187	+15%

The flat-operating-income bar needs revenue growth of about +24%, two points above the baseline. The feed's year-over-year revenue growth has run +12%, +34%, +26% and +22%, so two points is well inside the noise. The Sep-25 comp (+34%) is the toughest in the series, so I lean toward the left half of this table. I'm not calling the print a layup.

A gate that neither of us can call is not information. It also can't resolve the verdict, which we agreed on. So I accept the three filing gates in front of the starter but not the print.

2. "Needs to triple" is the mismatch you already conceded¶

Forward EPS of $3.06 on an unspecified, likely non-GAAP basis, compared with GAAP TTM EPS of $0.97, overstates the leap. You said last round that neither of us knows by how much. Keep it out of the tally until the basis is known.

3. "Free information" is also priced information¶

The June quarter had to be public before the 09-22 spike, since the next report isn't due until November. The market paid $333 with a 7.1% operating margin already in hand. Reading the 10-Q protects me from misunderstanding what I own, and I'll do it. It isn't an edge over the market. The print is different: it isn't free, it costs a quarter, and by the table above it is a coin flip.

4. The return shape makes confirmation more expensive than 7%¶

The tools list +14.8% (04-24), +15.7% (06-01) and +17.2% (09-21), plus the 08-04 +17.4% the report omitted. Against those, the only large down day listed is −10.1% (06-23). The up-moves came in single sessions. The declines came as grinds over weeks, from 439 to 225 in about six weeks and from 333 to 238 in three, which a stop has time to work. This is in-sample, from one regime, in a window where price rose 49% from the April low, so discount it. It doesn't claim drift. It says a confirmation entry in this stock tends to buy after the gap.

The plan¶

Before any money: read the 10-Q for the net-over-operating gap, the stock-comp share of opex and Qualcomm's revenue share. If the gap is one-time, stock comp is a large share of opex, or Qualcomm's share is large and exposed, I don't start.
Starter: one-third of target, about 1.8% of capital (derived). It risks about 0.3% to a 198.17 stop, or about 0.5% through a 25% gap.
Second third: a retest of 219–226 that reclaims 226.
Final third: either September operating income at or above $163M (opex up about 2% or less, or revenue up about 24%), or a close above 255 with the MACD histogram turning.
Exits: sell a third at the ~270 cluster (+13.4%, derived) and move the stop to cost. Sell another third near 295.73 (+24.2%, derived) and trail the rest.
Walk away: a close below 198.17, a post-trial ruling that limits royalty uplift, or sequential opex of 3.5% or more with revenue growth in the mid-teens.

Where this leaves us¶

We agree on the facts: a great business at a rich price, in a primary downtrend, with a verdict that can't be bounded before February. We now agree on three of your four conditions (the gap, stock comp and Qualcomm's share), and I've put them ahead of the first dollar.

The one condition left is the print, and I'm declining it for four reasons:

Its pass bar sits inside the noise of revenue growth.
It can't resolve the verdict.
The 70% geometry says starting and waiting tie.
The gap-up shape makes waiting costlier than it looks.

The bad case for the starter is a few tenths of a percent of capital. The good case is similar in size, with a sell rule that captures it. If the filings clear, that is a cheap price to hold a position in a franchise whose gross margin and cash generation aren't in dispute, and then add only as the tape and the numbers earn it.

My answer is a gated, staged starter in ARM, not an all-in buy and not a wait for the print. Bull Analyst: # Bull Final: Gates Accepted, a Rule for the Central Case, and a Starter Sized to Be Wrong

"Derived" means my arithmetic on the tool outputs. Today's bar may still be partial.

What I'm giving up¶

Coin flip versus left half. You're right that I can't hold both. My base case is the +3.5% sequential-opex row: September operating income of about $143M, down 12% year over year (derived). The YoY headline is more likely down than up, and I'll say so.
The middle of the distribution had no rule. My plan covered the tails but not the most likely outcome. That's fixed below.
The stakes. I accept your numbers: about +0.47% of capital at best and 0.30–0.45% at worst. That is the right scale for a starter, and I won't dress it up as more.
Consensus. The only consensus-related datum we have is the 77.7x forward P/E, which points to a high bar. I can't claim consensus sits below my base case. The GAAP-versus-forward basis caveat stands.

Where I still push back¶

1. "Toughest comp" is a growth-rate comp, and the bar is a level. - Sep-25's +34% came off a depressed Sep-24 base of $844M. - At +22%, Sep-26 revenue is about $1,385M, up 7.4% from June's $1,289M. Last year's June-to-September step was +7.8% ($1,053M to $1,135M). - Flat operating income needs about $1,407M, a +9.2% step. That is a bigger seasonal step than last year's, but not a miracle. - Seasonality isn't established. The year before, the same step was −10.1% ($939M to $844M). - The "deceleration" series (+34%, +26%, +22%) also skips March, where the implied quarter is about $1,490M.

So the bar sits above my base case but inside the range of this company's lumpy quarters.

2. Waiting for the print doesn't dodge the print. In the martingale frame we both used, the expected reaction is zero whether I hold or not. What the print gives is fundamental information for deciding adds and exits, and my plan already uses it that way. The starter carries only gap variance, which is capped at about 0.45% of capital.

3. "Half a percent either way" is an argument against fussing. Because the starter barely matters, the adds are the real decisions, and the adds are gated. I claim no edge for the starter. It is defined-risk exposure to a name whose largest listed up-days (+14.8%, +15.7%, +17.2%, +17.4%) exceed its largest listed down-day (−10.1%). That is in-sample, so it's a sizing consideration and not drift.

4. The tape is mixed, not just negative. The weekly trend is down, and I agree on that. But the one-month return is flat ($239.01 on 09-14 to $238.01, about −0.4%, derived). Highs have stepped down (439, 333, 307) while lows have held in a 225–244 band, which is compression. I'm not claiming drift from it, and I'm not conceding it either.

Step 0: pre-registered gates¶

You asked for numbers written down before the filing is opened. Here they are. An unresolved gate counts as a fail.

Gate	Line (yours, accepted)	Notes
Net-over-operating gap	Don't start if more than half of the ~$140–150M unexplained is non-recurring	Equals underlying June EPS under ~$0.18 (derived, ignores tax)
Stock comp	Don't start if above one-third of opex (~$387M on June's $1,162M, derived)	I'll also record its share of the $253M YoY opex increase
Qualcomm	Don't start at 10% or more of revenue, or if any part is tied to the disputed terms	See below

Stock comp and the September step. The 05-15 grants covered only about six weeks of the June quarter. A full quarter of expense lands in September, which may be part of the +3.3% and +3.7% seasonal steps. That is my inference. The 10-Q can confirm or kill it.
Qualcomm disclosure. From general accounting practice, not a tool output: if no customer at or above 10% of revenue is named, Qualcomm is likely below your line. I'd verify that. It does not clear the "tied to disputed terms" half, which I'd read from the legal-proceedings section.

The rule for the central case¶

Assumptions: sequential opex of +3.5% and gross margin of 97.2% (derived, one-quarter illustration).

Sep-26 operating income	Revenue growth needed (approx.)	Action
$163M or more	~24%+ (or opex up ~2% or less at +22%)	Release the third tranche
$120–162M	~20–24%	Hold the starter, no adds. My base case sits here
Under $120M	Under ~20%	Cut the starter in half
About $80M or less	~16% or less	Exit and re-underwrite

If sequential opex comes in at 5% or more, the lever thesis is failing regardless of the headline, and I cut in half. A gap through 198.17 stops me out before any of this matters.

Why I still take the starter¶

I'm not claiming edge. The case is this:

The margin problem sits below gross profit. In June, gross profit rose $230M on $236M of added revenue, while opex rose $253M (derived).
The cash engine is intact: $902M of operating cash flow and about $2.6B of net cash (derived).
The print can't resolve the verdict, which we agreed runs until about February. It can only resolve the opex line, and I use it for adds.
"Already in the price" is true at $238, $333 and $153 alike. It sets the hurdle and doesn't pick an entry date.

The plan¶

Gates first. No order today.
Starter: one-third of target, about 1.8% of capital. Stop-out costs about 0.30%, or about 0.45% through a 25% gap (derived).
Second third: reclaim 226 after a retest of 219–226, with the gates cleared.
Final third: September operating income of $163M or more, or a close above 255 with the MACD histogram turning.
Exits: sell a third at ~270 and move the stop to cost. Sell a third near 295.73 and trail the rest.
Walk away: a close below 198.17, a post-trial ruling that limits royalty uplift, or the exit row above.

Where this leaves us¶

We agree on the facts: - a great business at a rich price; - a weekly downtrend; - a verdict unresolved until about February; - no chart edge; - filings before the first dollar.

The one open question is whether a starter that risks at most 0.45% of capital, now with a written rule for every print outcome, goes in before November once the gates clear. If you're right about the skew, waiting saves a few tenths of a percent. If I'm right about the gap shape, starting earns about the same.

My call is a gated, staged position in ARM. No order today, the first dollar only after the three filing reads clear, and adds earned by the numbers.

Bear Researcher¶

Bear Analyst: # Bear Case for ARM: A Good Business Priced as If Nothing Can Go Wrong

You were candid about your caveats, and I'll concede what's real: the 97.5% gross margin, the net-cash balance sheet, and 22% revenue growth. Nobody is arguing ARM is insolvent. My argument is that the price already assumes the franchise is flawless, and the evidence this week says it isn't.

Figures marked "derived" are my own arithmetic on the tool outputs.

1. "A reset price" is not a reset¶

You anchor on the $439 peak, a blow-off day on 34.2M shares, so everything looks cheap against it. Look at the other anchors:

$238 is 49% above the 04-15 close of $159 and 2.4x the 52-week low of $100.02.
It is still 245x trailing earnings, about 49x sales, and 29.5x book.
ARM went from $243.98 to $333.20 in four sessions, then back to $238 in three weeks. A stock that can't tell $333 from $238 in 21 days has no valuation anchor. Whatever took it from $333 to $238 can take it to $198, or lower.

Your closing question, whether the stock is mispriced at $238, has no obvious answer from these facts. I'd say it is still priced for perfection.

2. The verdict: you promised to address precedent and didn't¶

In Section 3 you wrote that "the legal risk that matters is precedent for Arm's royalty-uplift strategy, and I'll address it below." Your memo never returns to it. Instead you lean on "$1 in damages," which is the wrong metric.

Barchart's framing is a "$4.9 billion business model on trial." The stake is what Arm can charge its largest licensees, not what it pays Qualcomm. A liability finding with nominal damages can matter more than a big check, because it limits the uplift strategy that supports the multiple.
Your "$1" comes from Arm's own statement, quoted by a StockTwits user. Three independent outlets (Investing.com, Motley Fool, Simply Wall St.) framed the result as a Qualcomm win, and the market sold 6.8% on it.
On your own reading, the jury still found for Qualcomm on two claims.
If TIKR's "hung jury" is right, the overhang is a retrial, not a resolution. Either way, post-trial motions and appeals keep this unresolved well beyond the next print.

3. The fundamentals show the opposite of operating leverage¶

You called margin compression "the bear's best fundamental point," then labeled it an "investment phase." Here is the June quarter over three years:

June quarter	Revenue	Operating income	Operating margin
2024	$939M	$182M	19.4%
2025	$1,053M	$114M	10.8%
2026	$1,289M	$91M	7.1%

Revenue is up 37% over two years and operating income is down 50%. Opex grew about 26% and then 28%, both times faster than revenue. "Investment phase" is a promise that leverage arrives later. Two years in, the data hasn't shown it.

Growth is decelerating. Year-over-year revenue growth in the feed went +34% (Sep-25), +26% (Dec-25), then +22% (Jun-26), at 49x sales.
The EPS doubling is below the line. Net income was $270M against $91M of operating income. Even at a generous 5% yield (my assumption), $3B of cash earns about $38M a quarter. The rest of the roughly $179M gap is unexplained, and you said you can't explain it. EPS went from $0.12 to $0.25 while operating profit fell.
The forward multiple needs a margin miracle. Forward EPS of $3.06 on about 1.07B shares (derived) means roughly $3.3B of net income. Even on 22% revenue growth (about $6.3B), that is a net margin near 52%, against 20% TTM and a 7.1% operating margin last quarter. The basis and period of forward EPS are unspecified and may be non-GAAP, but that only means the real bar is higher.
The next print is not a layup. If Jun-26's growth rates repeat in September, Sep-26 operating income lands near $140M against $163M a year ago (derived illustration, not a forecast).

4. The cash flow is flattering on inspection¶

TTM FCF of $1.33B is 191x at a $254B market cap (derived).
Q1 FY27's $705M is 53% of that TTM figure. The other three quarters average about $208M. The reported TTM implies the March quarter was near zero, so cash flow is lumpy rather than a run-rate. Annualizing the best quarter on record still gives about 90x FCF.
Operating cash flow was nearly 10x operating income ($902M vs. $91M). Current liabilities rose 16% from March to June. The tools don't break this out, but that gap usually means billing and working-capital timing, and timing reverses.
The fortress balance sheet is small relative to the price. Cash of $3.06B is 1.2% of market cap.
Capex of about 15% of revenue and opex up 28% don't look asset-light. Critics allege Arm is moving into its own silicon and competing with customers. The tools can't confirm that, but if it's true, a 97.5% IP gross margin is not the margin to capitalize.

5. Your technicals cherry-pick the short timeframe¶

The oversold signals are weaker than they look.
The daily z-score of -2.00 is measured against a 20-day mean (about $290) inflated by the 09-17 to 09-23 spike. Weekly is -1.05 and monthly is +0.70, so neither higher timeframe is stretched.
The lower Bollinger band at 238.05 isn't a floor. It will fall as spike days roll off.
RSI at 35.87 isn't oversold (that's below 30). TD counts are +5 daily, +1 weekly and +2 monthly, so there is no higher-timeframe exhaustion.
The primary trend is down. The weekly SuperTrend (Tier 1) is DOWN, and the monthly UP reading ranks below it. The MACD histogram (-7.62) has made new lows for eight sessions, and OBV is sloping down.
ATR: you said today's drop was "less than one ATR." The drop was 17.38 points (255.39 to 238.01) against an ATR of 17.28, and today's true range was about 17.84 (derived). You compared a percentage of the prior close to an ATR percentage of today's lower price. More important, a 7% day is "normal" for this stock, and that is a risk, not a comfort.
Today's candle: it gapped down (open 248.00 vs. prior close 255.39) and closed 0.46 above the low. The 10-13 bounce on 6.78M shares failed the next session.
The 200 SMA rising every day is partly mechanical. The 52-week low is $100.02, so the older prices rolling out of the window are plausibly far below $238.
The 219–226 "support" is thin. It is three next-day bounces, which you conceded, and each bounce made a lower high: 439, 333, 307.

6. Macro cuts both ways with a 3.79 beta¶

You said the hike path is "largely in the price." The evidence is that this week the odds of another hike rose 8pp to 86%, and three-hike odds rose 9.8pp to 20%. ARM fell during that move. Hot CPI, global bond yields surging, oil above $100, and chips sold while banks rallied all describe a hostile tape for long-duration equities.

Recession risk of 8% is beside the point. ARM's risk is the discount rate, not demand. You also invoke a 3.79 beta only for the upside. If yields keep rising, it magnifies the downside.

7. Insiders and sentiment¶

Denominator: $72M against a $254B market cap is the wrong comparison. The signal is $72M of sales against $0 of purchases, at $148, $208, $300, and $393.
Sales were not only at low prices. Haas sold at about $160, but Bartels ($393), Eaton ($252–291) and Abbey (up to ~$400) sold above today's price. A blackout may explain silence now. It doesn't explain six months of zero buys, including at $199–$215.
Sentiment is a contrarian warning. A retail skew of 12:2 bullish, "who bought the dip?" posts, and call-buying into a -6.8% day are not what bottoms usually look like. The retail bulls' own lines also broke. "Still good above $240" and "close over $245 is monumental" both failed at $238.01, and a cluster of $235 stops sits just below.

8. Your risk plan¶

You will average into $222–238 with a stop at $198. That stop is 16.7% away, about 2.3 ATRs (derived). ARM had a -10.1% day on 06-23 and a +17.2% day on 09-21, so a stop is not a guarantee. Take a valuation illustration: 50x forward EPS of $3.06 is $153 (derived), close to the April 15 close of $159. That is still a premium multiple, and it assumes the $3.06 gets delivered.

My answer to your challenge¶

You asked why a net-cash, high-margin business should stay down 46% over a verdict with $1 in damages. It's the wrong question on two counts.

The verdict risk is about royalty-rate precedent and a possible retrial, not damages.
Quality isn't the issue. The issue is what you pay: roughly 191x TTM FCF and 245x trailing earnings for decelerating growth, falling operating income, and a legal setback to the uplift thesis, in a tightening-rate environment.

Count the unknowns in your memo: the verdict scope, the forward-EPS basis, the net-versus-operating gap, 10b5-1 status, option strikes, the earnings date, the verdict timing, and a possibly partial bar. Your quality case rests on verified past facts. Your re-rating case rests on unverified future ones.

What would change my mind: - Opex growth below revenue growth in the September quarter. - A filing that explains the net-to-operating income gap. - Post-trial rulings that clearly preserve royalty uplift. - A daily close back above the 270 cluster with a MACD histogram turn. - Insider buying.

Until then, I'd rather wait for a lower price than average into a falling, high-beta name whose multiple has no anchor. Bear Analyst: # Bear Rebuttal: The Option Is Real, but It Doesn't Cover the Price

You gave real ground, so I'll do the same before pressing where I think your case still fails. "Derived" marks my own arithmetic. Assumptions are flagged. Today's bar may be partial, and the verdict date (about 10-13/10-14) is inferred from the StockTwits window and the price action.

What I'm giving up¶

Retrial. It rested on one undated TIKR headline. I withdraw it.
"Three outlets." It was two, Investing.com and Simply Wall St. Motley Fool's headline describes the price move, not the verdict.
The June-quarter table. Three points from one quarter a year was thin. Margins in the feed are lumpy, and Sep-24's 7.6% was followed by 17.8%. The year-over-year comparisons are mixed: up in Sep-25, down in Dec-25 and Jun-26.
Insiders and sentiment. I'm retiring both as arguments. RSU-compensated executives rarely buy on the open market, and insiders were also early sellers at $148–$215 on the way to $439. They were poor timers in both directions.
$153. It was an illustration at a multiple I picked, not a target.
Cash flow. We've converged. TTM FCF isn't a run-rate, and neither of us can resolve the implied March quarter.
Non-GAAP direction. You're right that comparing non-GAAP forward EPS to a GAAP net margin overstates the leap. Neither of us knows by how much, and you've said you don't underwrite the $3.06. I'll come back to that.

1. The opex lever is real, but your table is missing a row¶

I rebuilt your table (revenue +22%, gross margin held at 97.2%, June-quarter run-rate base) and added the case that has actually happened twice:

Next-12-month opex growth	Operating income	Operating margin
+28% (the last two June quarters, +26% and +28%)	~$165M	~2.6%
+22%	~$443M	~7.0%
+15%	~$769M	~12.2%
+10%	~$1,001M	~15.9%

Your table starts at "no leverage" and only improves from there. The observed trend is the first row, and that row nearly erases operating income.

The upside is also too small to reach the price:

Your best case against the price. $1.0B of operating income against a $254.2B market cap is about 250x.
What the price requires. At a generous 35x after-tax multiple and a 25% tax rate (both my assumptions), $254B needs about $9.7B of pre-tax profit. That is roughly 10x your best case. At a 40% operating margin (also assumed) it means about $24B of revenue, 4.7x TTM, or about eight years of 22% growth.
The lever's size. Closing the gap from the +28% case to the +10% case adds about $836M of annual operating income. Capitalized at 35x, that is about $29B, or 11% of market cap (derived). That is real, but it is about 1.5 ATRs of price. It does nothing for the other 89% of the price, which depends on years of compounding that November can't confirm.

You also can't buy "an option on the opex line." You buy the whole stock at 49x sales and 245x trailing earnings. The premium on this option is $254B.

2. The verdict's evidence arrives after your catalysts¶

You said the commercial channel is "observable in royalty and licensing revenue" and pointed to 22% growth "with this litigation live." That doesn't work on timing:

June-quarter revenue predates the verdict by about 3.5 months. It can't show a verdict effect.
The September quarter, reported in early November, also predates the verdict. The December quarter, reported around February (my background expectation, not from the tools), is the first with any post-verdict negotiation. Multi-year licensing terms phase in slowly after that.
So the November print can't resolve the biggest risk. A clean opex line does not tell us whether other licensees now negotiate with a stronger hand. That overhang runs through several quarters at 49x sales.
Counterparty exposure. Your point that a jury verdict doesn't bind other licensees is plausible. It is also your reasoning, not a tool output, and I'm not a lawyer either. It says nothing about Qualcomm itself. How much of Arm's royalty stream Qualcomm represents is the number needed to bound this risk, and neither of us has it.

3. The attribution of the slide is inconsistent¶

Your opening said most of the slide (−17% from 10-02 to 10-13) came before the verdict, so the verdict was a catalyst, not the cause. Your rebuttal says beta, rotation and the verdict explain the magnitude better than rates do.

Both can't hold. Beta and sector rotation are the hostile tape, and the evidence is that the tape hasn't turned:

Hot CPI and a global bond-yield surge.
Oil above $100.
Chips sold while banks rallied.
The week's Polymarket repricing moved from one more hike (14%, −7pp) toward three (20%, +9.8pp).

A 3.79 beta doesn't make the macro risk smaller. It is the amplifier that makes macro the largest risk in the position. FRED data was unavailable, so we're both leaning on headlines and prediction markets. That gives no basis to call yields "stabilizing."

4. Some of your invalidation list is checkable now¶

Two of your four "proves me wrong" items are answerable before you buy:

The net-over-operating gap. The June-quarter results are public, since the figures we're both quoting come from them. Net income was $270M against $91M of operating income. That gap is nearly twice operating income, and the filing that explains it exists today. Until someone reads it, the EPS doubling ($0.12 to $0.25) is not evidence of anything.
Forward EPS. You don't underwrite the $3.06, and the stock trades at 77.7x that number. You'd be paying a price you can't justify with the figure the market uses to justify it.

5. Your plan, by your own numbers¶

You were candid that a 198 stop and a 295.73 target need a ~41% hit rate, which is what a driftless walk gives. That is zero edge before slippage. You attribute the edge to opex convexity, which is symmetric, unsized (Section 1) and can't be resolved on the verdict question until February (Section 2).

Two further problems:

The stop doesn't protect you through the print. The stop at 198.17 is about 2.3 ATRs away, and ARM has had days of −10.1% and +17.2%. If the September opex line is your invalidation, the print gaps you rather than stops you. You've sized for that, and I respect it. But survivable isn't the same as worth doing.
The starter is the only piece with no confirmation. Your tranches 2 and 3 (a reclaim of 226 and a close above ~255 with the MACD histogram turning up) are essentially my change-my-mind list. We agree on two-thirds of the plan. The first third is the only part bought before the tape or the filings say anything, while:
the weekly SuperTrend is down;
the MACD histogram (−7.62) has made new lows eight sessions running;
the daily TD count is +5, and by convention it can run four more bars.

The price of waiting for your own tranche 3 is about 7% (255 vs. 238, derived). The price of being early is 16.7% to your stop. I'll be fair about the cost: if the print is clean and the stock gaps up, I pay more. That is what information costs. With lower highs at 439, 333 and 307, the stock has to retake 255 and then the ~270 cluster before it is repaired anyway, so you'd likely still have room to buy.

Bottom line¶

We agree that ARM is a great business at a rich price in a primary downtrend. The disagreement is narrower than the headline fight, and I think it favors waiting:

The opex lever is worth roughly 11% of market cap at a generous multiple. Its downside case, the one that has actually occurred, takes operating income to about $165M.
The verdict's commercial effect can't show up in the November print.
The macro drivers of the slide haven't reversed, and a 3.79 beta turns that into the dominant risk.
Your own plan concedes zero chart edge, and its earnings-edge leg is unsized.

My view: don't initiate ahead of the print. Treat a daily close below ~233–234 as opening the 219–226 zone. Revisit on a close above 255 with a MACD histogram turn, and above the ~270 cluster for a real repair.

What would change my mind: - September-quarter opex growth below revenue growth. - A filing that shows the net-over-operating gap is recurring and explained. - Post-trial rulings that clearly preserve royalty uplift. - Evidence on how much royalty revenue Qualcomm represents, bounding the verdict risk. - Yields and hike odds stabilizing. Bear Analyst: # Bear Closing: Your Math Says Start and Wait Tie, So Information Breaks the Tie

"Derived" means my arithmetic on the tool outputs, with assumptions flagged. Today's bar may still be partial.

What I concede¶

Your 70% is right, and drift is the right frame. (238.01 − 198.17) / (255 − 198.17) = 70.1%, which matches the break-even from my own cost ratio. I'm dropping the "cost of being early vs. late" language.
Sequential opex is the better test. I accept it, though §3 shows it hurts you.
The 08-04 gap was omitted. The +17.4% day (239.06 to 280.56) is missing from the report's 15%+ list. Your table arithmetic checks out.
Your 4bp macro estimate is fair arithmetic on one week's change in hike count. I'll stop calling macro "dominant." With FRED down, it's unmeasured for both of us.
November can't resolve the verdict. We already agreed on this.

1. If starting and waiting tie, information decides, and the information is free¶

You've said franchise economics are "not valuation support." That leaves you with no argument for positive drift. Your own 70/30 geometry gives the starter an expected return of about zero before slippage and gap risk.

The stakes are also small. A 0.3% stop-out budget over a 16.7% stop distance is a position of about 1.8% of capital (derived). The good path, a move to 255, earns about 0.13% of capital. That is the entire cost of waiting in your best case.

Meanwhile, you moved two gates in front of tranche 2: the net-over-operating gap and Qualcomm's revenue share. Those filings exist today, and reading them costs an afternoon, not a price. If they're material enough to gate the second third, they're material to the first third. Your plan sizes the position before the one thing you agree could change it.

2. Your table shows no drift, and the profit was in selling strength¶

You marked both episodes at troughs (09-01, today). Here are the same entries marked at the 09-22 peak and today:

Entry	Price	Marked at 09-22 peak (333.20)	Marked today (238.01)
Aug low (08-03)	239.06	+39.4%	−0.4%
Aug "strength" (08-04)	280.56	+18.8%	−15.2%
Sep low (09-16)	243.98	+36.6%	−2.4%
Sep "strength" (09-18)	275.61	+20.9%	−13.6%

The mark date decides the answer. Every entry was up 19–39% three weeks ago.
Even the perfect low-buyer is underwater today. Net progress since the 08-03 close is −0.4%. That is evidence of zero drift, not positive drift.
Your "strength" entries aren't my rule. They are +13–17% gap-day closes, not "a close above 255 with the MACD histogram turning." For September, I can't tell that 09-18 was the first close above 255, since the 09-17 close isn't in my data. The low entries also needed hindsight to identify.
The gains went to people who sold strength. Your plan has a stop at 198.17 but no profit-taking level short of the 295.73 flip. It would have ridden both gaps up and back down, within about four and three weeks respectively.
The floor you're buying has been tested six times. Closes at 239.06, 234.82, 242.59, 239.01, 243.98 and 238.01 since 08-03 (derived) sit in a 234.8–244 band. Repeated tests tend to weaken a level, though that is chart convention, not a tool output. Today's bar gapped down and closed 0.46 off its low, with the MACD histogram at new lows.

3. Your sequential test: the pass bar is flat operating income¶

Opex here is gross profit minus operating income, derived:

Quarter	Opex ($M)	QoQ	YoY
Jun-25	909	n/a	+25.6%
Sep-25	943	+3.7%	+26.1%
Dec-25	1,027	+8.9%	+31.7%
Jun-26	1,162	+13.1% over two quarters (about 6.4% per quarter; the Mar-26 quarter isn't in the feed)	+27.8%

Opex growth has been 26–32% YoY in all four comparable quarters. It beat revenue growth once, in Sep-25 (+34%). The last two reported steps ran at about 6–9% sequentially. Your pass bar is under 2%.

Applying that to September (revenue +22% to about $1,385M, gross margin held at the latest quarter's 97.2%):

Sep-26 opex, QoQ	Opex ($M)	Operating income	vs. $163M last year
+2% (your pass bar)	1,185	~$161M	−1%
+3.5% (last two Septembers)	1,203	~$143M	−12%
+6.4% (last two reported steps)	1,236	~$110M	−33%

Your "good" print is flat operating income on 22% revenue growth. Forward EPS of $3.06 is about 3.2x TTM EPS of $0.97 (derived). A stock priced for that doesn't re-rate on "no worse than last year" unless consensus is much lower than that. Neither of us has consensus. So the starter is long a catalyst whose good case is "not worse," and whose probable case is a down-12% headline.

4. "Fixable" is doing a lot of work¶

Calling opex "discretionary" is an assertion. The tools don't break out the components. Two cautions:

Stock comp is sticky. The 05-15 grants fell inside the June quarter and included 265,643 shares to the CEO and 81,359 to the CFO. Insider sales in that window were near $393–$400. RSU expense is set at grant-date value and recognized over the vesting period, so a lower share price doesn't unwind it. This is my inference, and the stock-comp share of opex is a 10-Q question. Add it to your gates.
Cutting R&D is not free. At an IP company, R&D is the product that supports the royalty growth the multiple needs. The user claim that Arm is moving into its own silicon is unverified, but if it's true, rising opex is a strategy, not a mistake.

Your $902M of operating cash flow and $2.6B of net cash (derived) fund the spending. They are about 1% of a $254B market cap and do nothing for the price.

5. Where we stand¶

You say the only reason to wait is negative drift. I have four reasons, and I'm not claiming momentum is a large edge:

Your math ties start and wait. The 70% result is your own.
Information is free today. The gap, stock comp and Qualcomm exposure are in public filings you've already made gates.
Your case for positive drift is empty. You wrote that franchise quality is not valuation support. The tape is mildly negative: weekly SuperTrend down, MACD histogram at new lows, OBV sloping down, and lower highs at 439, 333 and 307.
Your best-case print is flat operating income, against a multiple that needs it to triple.

The unresolved verdict, with Qualcomm's revenue share unknown, is a risk that should be priced into the entry, not carried by the first third of a position.

My view: no position ahead of the filing read and the print. A daily close below about 233–234 opens the 219–226 zone, and I wouldn't buy there without the read either.

I'd stop objecting to a starter if: - The 10-Q explains the net-over-operating gap as recurring. - Stock comp is a modest share of opex. - Qualcomm's revenue share is small or capped. - Sequential September opex comes in under about 2% with revenue growth near 22%.

I'd get more bearish on: - Sequential opex growth of 3.5% or more with revenue growth in the mid-teens. - A close below 198.17. - A post-trial ruling that limits royalty uplift.

The disagreement is narrow. You want to own the franchise before the facts come in. I want to read the facts first, because on your own numbers waiting costs nothing and the facts can still change the answer. Bear Analyst: # Bear Final Word: We Agree on Today's Order, and Disagree on What the Print Is

"Derived" means my arithmetic on the tool outputs, with assumptions flagged. Today's bar may still be partial.

What I concede¶

Seasonal opex. The like-for-like June-to-September steps were +3.3% and +3.7%. My +6.4% row averaged Dec-to-Jun steps that include the fiscal-year-start step-up, so it's a stress case. I'll use +3.5% as the base.
"Needs to triple." It compares a forward EPS of unknown basis with GAAP TTM EPS. I'm dropping it from the tally, and the basis question stays open.
"Free information." Reading the 10-Q isn't an edge over the market, and the market paid $333 with the June numbers already public. It is ownership hygiene, which is the reason to do it first.
The six tests. That was chart folklore. I withdraw it.
The gap-day shape. It is in-sample, but I accept it as a sizing consideration. It isn't evidence of drift.
The sell rule. It fixes a real hole in your plan.

Where we've converged¶

Item	Status
Quality of the franchise (97.5% gross margin, net cash)	Agreed, and not in dispute
Chart edge	None, conceded by you
Verdict resolution	Not before February, agreed
Macro	Unmeasured, with FRED down
Start vs. wait in a driftless walk	A tie (70/30), agreed
Filings before the first dollar	Agreed (your Step 0)

Step 0 means the actionable outcome of this debate is no order in ARM today. What remains is a conditional question: once the filings clear, does the starter go in before the print?

1. By your own table, the print is not a coin flip¶

You called the print a coin flip, and in the same section you wrote that you "lean toward the left half of this table." Those can't both hold.

Your base row (revenue +22%, opex +3.5% sequentially) gives operating income of about $143M against $163M last year, which is −12%. You also wrote that we should expect an "ugly year-over-year headline" unless opex growth stays under about 2%.
Flat operating income needs revenue growth of about +24%. Growth has decelerated from +34% to +26% to +22%, and September faces the toughest comp in the series. Meeting the bar means re-accelerating against the hardest comparison.
Neither of us has consensus. Your position needs consensus to sit below your own base case. Nothing in the data says it does. The 77.7x forward P/E suggests a steep ramp is expected, though its horizon and basis are unknown.

2. Your plan has no action for its own central case¶

Walk-away: opex up 3.5% or more with revenue growth in the mid-teens or lower.
Add: September operating income at or above $163M.

At +22% revenue and +3.5% opex, neither triggers. That is your base case. The dead zone is wide. At 15–16% revenue growth, operating income is still only about $66–77M (derived), roughly down 55–60% year over year. Your plan holds through all of that, protected only by a stop 16.7% below the current price.

A plan should say what it does in the most likely scenario. Write that rule before the print. For example: "if operating income is under $163M but revenue growth is 18% or better, cut to half."

You also wrote that "a gate neither of us can call is not information." That has it backwards. Because we can't call the print, it carries information. Your plan already treats it as a gate for tranche 3 and for the walk-away. The only question is whether tranche 1 goes in ahead of it.

3. Pre-register the filing gates with numbers¶

"Large," "material" and "one-time" are undefined. A gate without a number lets you rationalize whatever you read. Here are my lines. They are arbitrary and mine, and the point is to write yours down before opening the filing.

The net-over-operating gap. Interest on $3.06B of cash at an assumed 4–5% explains roughly $30–38M of the $179M. That leaves about $140–150M unexplained. If all of it were one-time, underlying June EPS would be about $0.12, not $0.25 (derived, illustrative, ignoring tax). Line: if more than half the unexplained amount is non-recurring, I don't start.
Stock comp. Line: if it exceeds about one-third of opex, the opex line isn't a lever. It's a grant schedule set months ago.
Qualcomm's revenue share. Line: at 10% or more, or any part of it tied to the disputed terms, I don't start. This is the only number that bounds the verdict risk.

4. What the starter actually risks and earns¶

Your sizing is a 1.8% position (derived), with a stop-out costing about 0.30% of capital, or about 0.45% through a 25% gap.

Selling a third at +13.4% earns about +0.08% of capital.
Selling a third at +24.2% earns about +0.15%.
Holding the last third back to the 09-22 close of 333.20 (+40.0%) earns about +0.24%.

The full round trip back to the September peak pays about +0.47% of capital (derived). Under a driftless walk, every exit you've specified has zero expected value. For example, the chance of touching 270 before 198.17 is about 55%, and of touching 295.73 first is about 41% (derived).

So the entire debate is about roughly half a percent of capital either way, at zero expected value, with filing reads that cost nothing and a base-case print your plan doesn't cover. Your argument for starting now comes down to participating in a right tail you've told me is in-sample. That isn't a thesis.

Where I stand¶

No position in ARM today. We agree on that for the filings. I would also wait for the print, for three reasons:

Your own base case is operating income down 12% year over year, and you lean below it.
Your plan has no rule for that outcome.
The tape is mildly negative. The weekly SuperTrend is down, the MACD histogram (−7.62) is still making new lows, and highs have stepped down from 439 to 333 to 307. This is weak evidence, but you've given me nothing for the other side except franchise quality, which you agree is already in the price at 245x trailing earnings, ~49x sales and ~191x TTM FCF.

I'd stop objecting to a starter if: - The filings clear the three pre-registered lines. - You add a written rule for the base-case print. - Sequential September opex growth comes in at about 2% or less with revenue near +22%.

I get more bearish on: - A daily close below about 233–234, which opens the 219–226 zone. - A close below 198.17. - A post-trial ruling that limits royalty uplift. - Sequential opex growth of 3.5% or more with revenue growth in the mid-teens.

Quality isn't in dispute. The question is what the price already assumes, and a position that is flat in expectation, unprotected in the central case and worth half a percent of capital at best is not worth opening ahead of the data. Bear Analyst: # Bear Final Word: The Plan Is Now Mostly Mine, and Only the Starter Is Left to Argue

"Derived" means my arithmetic on the tool outputs, with assumptions flagged. Today's bar may still be partial.

What I'm giving up¶

The central-case rule. This was my main complaint, and your table fixes it. I checked its revenue thresholds against 97.2% gross margin and +3.5% sequential opex. They come to about +19.9%, +23.8% and +16.3% year over year, which matches your rows.
"Toughest comp." You're right that it's a growth-rate comp and the bar is a level. Flat operating income needs a +9.2% sequential revenue step, against +7.8% last year and −10.1% the year before. That is inside this company's lumpy range. Your base case is still −12% year over year.
My tape count. I listed the weekly SuperTrend, the MACD histogram, OBV and lower highs as separate signals. They are one price path read four ways, so I'll count them once, as weak. Your flat one-month return (239.01 to 238.01) and my −0.4% since 08-03 are the same round-trip fact, and neither shows drift.
Stock comp as evidence. I leaned on the 05-15 grants. Those were 467,731 shares to six named officers. Valued at the window's peak close of 439.46, that is about $206M. On an assumed three-year vest it is about $17M a quarter, roughly 1.5% of June opex (derived). Named-officer grants can't explain +$253M of opex growth. The gate stays because employee-wide stock comp is unknown, but I withdraw the grants as support.
"Already in the price." It doesn't pick an entry date. That cuts against my valuation case as a timing tool too, so my timing argument has to be information, not multiples.

Where it still doesn't close¶

1. A starter with no edge is just variance and friction¶

You've said three times that you claim no edge, and the martingale frame we both used makes the print's expected reaction zero. That makes the starter's expected return zero as well. What it adds is gap variance, stop slippage, and a position to manage.

Your answer is the gap shape: the listed up-days (+14.8%, +15.7%, +17.2%, +17.4%) exceed the listed down-day (−10.1%). Two problems:

The list isn't a clean screen. The report omitted the +17.4% day on 08-04, so it can't establish the largest down-day either. It also comes from a window that opens at $159 and runs 2.8x to the peak (derived), and a bull run will show that distribution.
Right skew with zero mean puts the median below the mean. The typical path is a small loss, paid for by rare large gains. That is a lottery-shaped payoff, and your adds already capture the right tail with confirmation.

2. The biggest unknown isn't on your gate list¶

Every round we've written "verdict scope unverified." Arm's statement says it won four claims and Qualcomm got $1 on each of two. Two outlets call it a Qualcomm win. TIKR says hung jury. The verdict form and the post-trial docket are public and cost an afternoon, like the 10-Q.

I propose Gate 4: what was decided, and what remains open (retrial, post-trial motions, schedule). Your own walk-away list includes "a post-trial ruling that limits royalty uplift." That event is on the court's calendar, not the earnings calendar. The starter would hold it with no ability to act before the gap. Under your rule, an unresolved gate counts as a fail.

I also accept your Qualcomm reading, with one limit. "No customer named at 10% or more" tells you Qualcomm is under my line, not how far under. The half of the gate that matters is whether any revenue is tied to the disputed terms, and that comes from the legal-proceedings section.

3. The gap gate is pre-registered for one quarter, but the gap is four quarters wide¶

The fundamentals report gives TTM net income of $1.044B and an operating margin of 7.6% on $5.156B of revenue. That implies about $392M of operating income and a gap of about $650M (derived). Interest on roughly $2.9B of average cash at 4–5% (my assumption) explains $115–145M. That leaves about $500M unexplained over TTM, against the $140–150M we pre-registered for June alone.

The base for 245x trailing earnings is the $0.97 TTM EPS, so a gate that tests only June can pass while most of that EPS stays unexplained.

One more inconsistency: the three reported quarters (Sep-25, Dec-25, Jun-26) sum to $439M of operating income. A 7.6% TTM margin then implies March-26 operating income near −$47M on about $1.49B of revenue (derived). Either March carried a large charge or the 7.6% isn't a TTM figure. I can't tell which. Both are reasons to read the filing, and unresolved fails the gate.

Pre-register it: apply the "more than half non-recurring" line to the TTM gap as well as to June.

4. In the central case, the print can't help the starter¶

Your base case is operating income of about $143M (−12% year over year), and your rule for it is "hold, no adds." So in the central case the starter neither earns nor learns anything from the print. Only the tails matter, and they are symmetric. I'm dropping the argument that the print's information justifies waiting for the starter. That information belongs to the adds, and your adds already use it.

Where we stand¶

Step	Your plan	My view
0. Gates before any order	Gap, stock comp, Qualcomm share	Agree. Add the verdict form/docket and the TTM gap
1. Starter, one-third (~1.8% of capital)	After gates, before the print	After gates and the print
2. Second third: retest and reclaim 226	As written	Agree
3. Final third: Sep op income ≥$163M, or close >255 with MACD turn	As written	Agree
4. Exits: a third at ~270, a third near 296	As written	Agree
5. Walk-away: close <198.17, adverse ruling, exit row	As written	Agree

The whole disagreement is row 1. The stakes are a starter that risks 0.30–0.45% of capital for about +0.47% at best. Neither of us should spend more words on it.

What stays true regardless¶

The conceded points don't change why the stock isn't cheap:

Valuation: 245x trailing earnings, about 49x sales and about 191x TTM FCF (derived).
Operating costs: opex has grown 26–32% year over year in all four comparable quarters. June-quarter operating income fell about 20% on +22% revenue.
The legal question: the verdict's commercial effect can't appear in a reported quarter before about February (my background expectation, not from the tools). November tells us about opex, not licensing power.
Macro: the Polymarket odds are 97% for no cuts and 86% for another hike. FRED was down, so yields are unmeasured, not benign. A 3.79 beta amplifies whichever way they go.

My position¶

No position in ARM today. We agree on that. If the gates clear and you open a 1.8% starter, I won't call it reckless, since the worst case is under half a percent of capital. I still wouldn't take it, because a zero-edge position needs a reason, and the only reason offered is an in-sample skew.

I'd stop objecting to a starter if: - The 10-Q clears the three pre-registered lines, including the TTM gap. - The verdict form and docket show a bounded, non-retrial outcome with no open ruling on licensing terms. - September sequential opex comes in at about 2% or less with revenue near +22%.

I get more bearish on: - A daily close below about 233–234, which opens the 219–226 zone. - A close below 198.17. - A post-trial ruling that limits royalty uplift. - Sequential opex growth of 3.5% or more with revenue growth in the mid-teens. - A filing showing the net-over-operating gap is mostly non-recurring.

ARM is a great business. The case for waiting is that the price already assumes it, the facts that could change the answer are public, and a position held without them has no edge.

Research Manager¶

Recommendation: Underweight

Rationale: This debate converged more than most. By the end, both sides agreed on nearly all the facts and most of the plan. They differ only on whether to open a small starter before the November print.

The bull's case: - ARM is a high-quality franchise: 97.5% gross margin, about 22% revenue growth, $902M of June-quarter operating cash flow, about $2.6B of net cash, and a 5.25 current ratio. - The stock is about 46% below its $439 peak. - The verdict carried only $1 in damages on each of Qualcomm's two winning claims. - In the June quarter, gross profit rose $230M on $236M of added revenue. The margin problem sits in opex, which can in principle be fixed.

The bull then conceded most of the rest: - No chart edge. The 198 stop against a 255 target is about a 70/30 tie under a driftless walk. - No underwriting of the $3.06 forward EPS. - The ATR comparison was wrong, sentiment is not a signal, and the opex 'option' is worth roughly 11% of market cap, not the whole price. - The base case for September is operating income of about $143M, down about 12% year over year. - Filings must be read before the first dollar goes in.

The bear also gave ground: the retrial claim, the insider and sentiment arguments, the $153 illustration, the +6.4% opex stress row, and 'needs to triple.' But the core bear case survived: - Valuation is still steep: about 245x trailing earnings, about 49x sales and about 191x TTM FCF. - Opex has grown 26–32% year over year in all four comparable quarters, faster than revenue in three of them. - June-quarter operating income fell to $91M (7.1% margin) on +22% revenue, while revenue growth slowed from +34% to +26% to +22%. - EPS roughly doubled while operating income fell. Net income was $270M against $91M of operating income. - At the TTM level, about $500M of the net-over-operating gap is unexplained, and the reported 7.6% TTM margin implies a March quarter near −$47M of operating income. That puts the $0.97 EPS base behind 245x in question. - The verdict's scope (Arm win, Qualcomm win, or hung jury) is unresolved. Its commercial effect cannot show up in reported numbers before about February. - The weekly SuperTrend is down, the MACD histogram (−7.62) is at new lows, and highs have stepped down from 439 to 333 to 307. - Macro is hostile and unmeasured: 86% odds of another hike, 97% no cuts, FRED unavailable. A 3.79 beta amplifies whichever way rates go.

What decided it: the bull's own closing plan places no order today and admits zero edge on the starter. The positive case comes down to franchise quality, which both sides agree is already in the price, plus an in-sample right-skew in gap days. The bear's points about the expensive multiple, operating deleverage, an unexplained earnings base and an unbounded legal overhang are not refuted. They are deferred to filings and a print whose central case is a down-year headline.

That tilts the risk/reward against carrying a full standard allocation into November. The case is not strong enough for Sell: - The franchise and balance sheet are not in dispute. - Both sides accepted roughly zero drift. - The legal damages are nominal.

So the call is Underweight: trim to below a standard allocation, don't initiate, and re-earn exposure through pre-registered gates.

Missing from the evidence: consensus estimates, the basis and horizon of forward EPS, the confirmed earnings date, Treasury yields (FRED down), the verdict form and docket, and whether today's bar is final.

Strategic Actions: 1. Today: - Do not initiate a new position. - If you hold a standard allocation, cut it to about 50%. Sell about half of the trim now; price is at the lower Bollinger band (~238), so don't dump the whole amount into the low. - Sell the rest of the trim on any bounce into 255–270 within the next two weeks. - If there is a daily close below about 233–234 first, sell the rest of the trim immediately. If you are already at or below half weight, hold and do not add.

Hard risk lines on the remaining position:
Exit fully on a daily close below 198.17, the monthly SuperTrend.
ATR is about 17.3 (~7.3%) and beta is 3.79. Assume a stop can be gapped by 10–17% and size so that a 25% gap through 198 costs no more than about 0.5% of capital.
Read before any re-add. An unresolved gate counts as a fail.
(a) June net-over-operating gap: fail if more than half of the ~$140–150M unexplained amount is non-recurring.
(b) TTM gap: fail if more than half of the ~$500M unexplained amount is non-recurring. Also explain the implied ~−$47M March-quarter operating income.
© Stock comp: fail if it exceeds about one-third of opex (~$387M).
(d) Qualcomm: fail if it is 10% or more of revenue, or if any revenue is tied to the disputed terms.
(e) Verdict form and post-trial docket: confirm what was decided, whether a retrial or open motions on licensing terms exist, and the schedule.
September-quarter print (early November, date unverified). Assumes about +3.5% sequential opex and 97.2% gross margin.
Operating income ≥$163M (roughly +24% revenue, or opex up ≤2% at +22%) with gates cleared: rebuild toward standard weight in thirds.
Operating income $120–162M (the base case): stay at reduced weight with no adds.
Operating income under $120M (revenue growth under ~20%): cut the remaining position by half.
Operating income ≤$80M, sequential opex ≥5%, or ≥3.5% sequential opex with mid-teens revenue growth: exit.
Technical re-add triggers. Each applies only once the gates are cleared.
A retest of 219–226 that closes back above 226.
A daily close above 255 with the MACD histogram turning up.
A close above the ~270 10-EMA/50-SMA cluster, which signals real trend repair.
Profit-taking on any re-added size:
Sell a third near 270 and move the stop to cost.
Sell a third near 295.73, the daily SuperTrend.
Trail the rest.
Escalation:
Downgrade to Sell on any of: a close below 198.17, a post-trial ruling that limits royalty uplift, filings showing the earnings gap is mostly non-recurring, or a Qualcomm exposure that is large and disputed.
Upgrade to Hold or Overweight on: all five gates clean, September operating income ≥$163M, and a close above 255–270.

III. Trading Team Plan¶

Trader¶

Action: Sell

Reasoning: The research plan is Underweight, which maps to Sell: cut exposure, do not initiate, and re-earn it through gates. The valuation is still steep (about 245x trailing earnings, 49x sales), opex is growing faster than revenue, and the earnings base is unexplained. Both the bull and the bear agree the franchise quality is already priced in. The technicals agree: the weekly and daily SuperTrends are down, the MACD histogram (-7.62) is at new lows, and price is 11-12% below the 10 EMA and 50 SMA, which sit near 270. It is not a full exit, since the monthly SuperTrend is still up, the 200 SMA (222.19) is rising below price, the balance sheet is strong and the legal damages are nominal. Price is on the lower Bollinger band with a daily z-score of -2.0, so the plan sells about half the trim now and the rest into a bounce rather than dumping everything at the low. Today's bar may be partial, and the earnings date, consensus and the verdict form are unverified.

Entry Price: 255.0

Stop Loss: 198.17

Position Sizing: Portfolio context was not provided, so apply this to your own position. Do not open a new position. If you hold a standard allocation, cut it to about 50%. Sell about half of the trim now, near 238. Sell the rest of the trim on a bounce into 255-270 within about two weeks (255 is the entry price level above). If ARM closes daily below about 233-234 first, sell the rest of the trim immediately. If you are already at or below half weight, hold and do not add. Exit the remainder fully on a daily close below 198.17, the monthly SuperTrend stop. ATR is about 17.3 (~7.3%) and beta is 3.79, so a stop can gap by 10-17%. Size the remainder so that a 25% gap through 198 costs no more than about 0.5% of capital. Re-add only after the five filing gates clear and September-quarter operating income is at least $163M, then rebuild in thirds.

FINAL TRANSACTION PROPOSAL: SELL

IV. Risk Management Team Decision¶

Aggressive Analyst¶

Aggressive Analyst: Neither of you has spoken yet, so I'll go first and take on the objections I expect.

Most people will call a Sell here the timid trade. I think it's the aggressive one. We're being asked to hold a beta-3.79 stock at 245x trailing earnings and about 49x sales, after it has given back its whole September spike. It closed at 238.01, below the 243.98 close from before the four-day run to 333. It's 28.6% under the 9/22 close and 45.8% under the June peak. Holding that and hoping is the passive choice. Taking a decisive action, then holding the upside tail with a defined stop, is the active one.

Conservative analyst, I expect you'll say the plan doesn't go far enough: weekly and daily SuperTrends are down, the MACD histogram is at a new low of -7.62 after eight straight declines, insiders sold about $72M and didn't buy the dip, and the rate market says no cuts and another hike (86%, up 8 points this week). I agree with every one of those facts, and they're why we're selling. But a full exit at the lower Bollinger band, with the daily z-score at -2.0, means dumping into the most stretched point of the move. The monthly SuperTrend is still up, with its stop at 198.17. The 200 SMA at 222 is rising. The company has $3.1B in cash and almost no debt. Three times in this window the stock bounced hard off the 219-226 area: +7% the next day, +17%, then +4%. That's thin evidence, but with a stock this violent, selling everything at the low gives away the one thing a high-beta name pays you for, which is the snapback. The plan sells about a quarter of the position now and another quarter into 255-270, where the 10 EMA and 50 SMA sit stacked and where the last two closes failed. The remainder stays on with a hard exit at 198.17. That keeps the explosive upside and still cuts the risk.

Neutral analyst, I expect you'll say to hold: sentiment is mildly bullish, there's unusual call activity, and retail is buying the dip. I wouldn't lean on any of that. The sentiment report itself calls its confidence low. It covers about one day, the Reddit feed is off, and only 14 of 30 posts were tagged. The 12-to-2 bullish skew comes from roughly nine unique authors, and one account wrote three of those posts. The "$240 gap fill" and "still good above $240" calls have already broken, since we're at 238. The posts quote a $235 stop, and the plan's trigger sits at 233-234. That's a cluster of stops under the market, and I want to sell before it gets tested, not after. The unusual call activity is undated and has no strikes, so it could be pre-verdict. Bounce attempts have also been sold. On 10/13 the stock ran to 260 and closed at 255, and on 10/14 it opened at 248 and fell 6.8%.

On fundamentals, revenue is up 22% and the gross margin is 97%, and I don't dispute the franchise. But in the June quarter operating expenses grew about 28% against 22% revenue growth, and operating income fell about 20% year over year to $91M. Net income was $270M, so nearly two-thirds of it came from below the operating line, and nobody has explained it. At 77.7x forward earnings, the price needs EPS to roughly triple on a basis we haven't confirmed. And the re-add gate asks only that September-quarter operating income reach $163M, which is what the company earned a year ago. If a 245x stock can't clear that bar, I don't want to own more of it.

On the legal side, the headlines conflict. Some say Qualcomm won, one says hung jury, and retail says Arm won four claims with $1 in damages on the others. I don't know the verdict form, and the plan says so. But the stock fell anyway, and the whole September rally is gone. At this multiple the market doesn't need a legal disaster to reprice it. The multiple is the problem. It also sits on top of oil above $100, rising global yields, and rotation out of chips.

On execution, the plan has several safeguards. It doesn't open anything new. It stages the exit. It has a 233-234 trigger and a 198.17 stop. The sizing rule says a 25% gap through 198 should cost no more than about 0.5% of capital. At today's price that works out to a remainder of roughly 1.3% of capital, and whichever limit is tighter, the 50% cut or that one, should govern. With an ATR of 17 and a beta near 4, a gap through the stop is a real possibility, so I'd rather size for it than pretend it can't happen.

We're also not predicting a collapse. We're cutting a crowded, richly valued, high-beta position while keeping a small, capped piece to catch the bounce. If ARM rips back to 295, we've given up a little. If it breaks 233 and heads to 198, we've saved a lot. I'd take that trade.

FINAL TRANSACTION PROPOSAL: SELL Aggressive Analyst: Conservative, Neutral, you've both moved toward my plan more than you admit. Let me concede what's earned and then say where you're still wrong.

Conservative, you're right about the cash. It's about 1.2% of market cap, roughly $2.90 a share, and it protects against insolvency, not multiple compression. You're also right that the 200 SMA is rising because last year's cheap prices are rolling out of the window, and that the daily z-score of -2.0 is partly an artifact of a window still holding the September spike. I'm dropping all three as reasons to hold. I keep a remainder because the stock has gone 159 to 439 and 224 to 333 inside this data, and a cap-sized piece is the cheapest way to own that tail. That's a sizing argument, not a floor argument.

Where you're wrong is the execution. You say a close-based trigger at 233 fires after the damage and want a resting order. But this stock traded through 233 intraday on August 3, September 1 and September 3 and closed above it each time. On August 3 the low was 219, the close was 239, and the next day was +17%. A stop 2% under the market on a 7.3% ATR name is a noise sale. You can't call three bounces thin and then treat a wick below 233 as a verdict. Neutral's hybrid is better: a close-based trigger at 233-234 and a hard intraday trigger near 219. I'll take it.

I'll give you the sizing in full. A 25% gap through 198 lands near 148.6, 37.6% below here, and the stock was at 159 in April, so that isn't a fantasy tail. Use the tighter reading, about 1.3% of capital, not the looser one Neutral flagged that would let you hold nearly double. The tighter limit always wins.

On the re-add gate, I called $163M a low bar, and your opex arithmetic says it isn't. Revenue has to get to roughly $1.36B even with opex flat. That supports my valuation case. It doesn't support dumping the remainder, though. Missing a gate means we don't add, not that we sell, and a cap-sized remainder is already sized for a bad print.

Neutral, you landed one hit I'll own. I threw out the sentiment feed and then used "stops under the market" to argue for urgency. I withdraw that. The 233-234 level stands on price structure, the 233.29 low from August 24 and the 234.82 close on September 1, not on nine StockTwits authors.

Your payoff math, though, assumes half the position is sold at 238. The plan is a ladder. If the stock runs to 295.73, the first quarter costs about 6 points and the second quarter, sold near 262, costs about 3, so roughly 9 in total. If it falls to 198, the first quarter saves about 4 and the second, sold on the 233 trigger, saves about 3.7, so roughly 8. That puts break-even in the mid-50s, not 60. The weekly trend, eight straight falling histogram bars and an 86% rate-hike market are more than a coin flip. And you called the risk budget the better case for selling. A beta of 3.79 position that's too big under any view is a sizing question, not an expected-value contest.

Now turn your own volatility math on your tranche. You say 255 gets touched within two weeks more often than not. On my rough numbers, not tool output, 233 is only 2% away, so it gets touched sooner and more often. On a no-drift assumption, 233 comes before 255 about three times in four. Most of the time tranche two sells on the trigger, not into the bounce. That's fine, it's what the ladder is for, but it means "I wouldn't sell most of the trim into this print" describes what your own triggers will usually do anyway.

So here's where I land. I sell a quarter now and open nothing new. Most of tranche two goes at 250-256, a small piece reaches for 268-272, and a hard date of October 28, or earlier if earnings are announced sooner, clears whatever is left. The close-based 233-234 trigger and the intraday 219 trigger protect the unsold trim. The remainder is capped at 1.3% of capital with a daily-close exit under 198.17.

You're right that the 6.8% drop today is only about a quarter of the dollar slide since October 2. The multiple is the problem. The verdict is the one near-term catalyst that could hand us a bounce to sell into, once people read the verdict form.

FINAL TRANSACTION PROPOSAL: SELL Aggressive Analyst: We've all landed on Sell, so I'll spend this on what I'm taking from you and the places where I think we're still giving away too much.

Conservative, you're right that the cap isn't a view, it's a loss budget, and with a 7.3% ATR and a beta near four it's in force today. Anything above the cap shouldn't wait for a bounce. Neutral's wording is the cleanest: sell the larger of a quarter and whatever gets you to the cap, and stage only what sits between the cap and half weight. For a big holder the cap decides everything and the ladder barely matters. Neutral, you're also right on my arithmetic. With the second quarter sold near 253 instead of 262, the forgone gain is about ten and a half points against about eight saved, so break-even is near 57%, not the mid-50s.

I'll take your halve-the-core rule on a daily close under 219 too. It's the gap nobody covered. A close there would be the lowest close of the whole decline and below the 200 SMA, so it's a real break, not a wick. It costs me half of a core that's already cap-sized, which is cheap. I also withdraw the verdict form as a catalyst to sell into. It's an unread document, and the ladder works without our knowing which way it reads. And 268-272 is a lottery ticket, a tenth of the trim at most.

Now where I'm holding. First, a quarter versus three-eighths. Conservative, your 77/23 point is good, but two corrections. My three-in-four was a touch against a touch, and the real trigger is a daily close, which fires less often than a wick. Since August this stock has traded through 233 intraday three times and closed above it every time. The limit side can also fill better than its limit. The 9/21 session opened at 294 off a 275.61 close, so a resting order near 253 on a gap day fills well above 253.

Neutral, this applies to your four points as well. The cost of waiting only appears if you combine 77/23 odds, five points of stop slippage, and no slippage in our favor on the limit. Under the no-drift assumption that produced 77/23, the expected fill is today's price by construction. Add slippage with nothing offsetting it and you've brought in negative drift through the side door. So the cost of waiting is a drift view, and the drift view is a tilt. On my rough math, not tool output, pure distance with no drift gives about 54-59% odds of hitting 198 before 295.73, right around the 57% break-even. The weekly trend, the histogram and the rate market tip it a bit further. That's enough to sell, but not enough to claim the extra eighth has an edge we can tell from zero. Waiting also isn't a bet against the thesis. The thesis is that the multiple is the problem and the size is wrong, not that tomorrow's drift is large. I'd rather pay a small price to see the final 10/14 bar, the verdict form and the next inflation print.

Second, the gap. Conservative, you got your one-third break-even by making a 25% gap to 148.6 the bad outcome. Neutral already said you can't pair a rare outcome with ordinary-leg odds, and the file backs that up. The technical report flags four up days of roughly 15 to 17% in this window, counting the 17% day after the August low, and one big down day, 10.1% on 6/23. The slide from 439 to 225 took six weeks, and nothing in the report flags a day anywhere near a 25% gap. Gap risk here is two-sided and has mostly run upward. The cap already sizes for the downside version, and I won't use that same gap to argue for dumping the core.

Third, the print. Conservative wants the core revisited a week before earnings and not carried by default. Neutral says the only question is whether the core still fits the cap, and I agree. The cap is already sized for a violent gap. A core you dump before every event is a trade, not a core, and the 15-17% days are the only reason to own one. Check the earnings date today, though. If it's earlier than early November, October 28 moves up with it.

So here's my plan. Today, sell the larger of a quarter and whatever gets you to the 1.3% cap, and open nothing new. Put most of the rest of the trim on a limit at 250-256, with a token piece, at most a tenth, at 268-272. The unsold trim sells at the next open on a daily close under 233-234, or immediately on an intraday break under 219. Clear whatever is left by October 28, or a week before a verified report date if that's sooner. The core stays at or under the cap through the print. Halve it on a daily close under 219 and exit the rest on a daily close under 198.17. Add nothing until the filing gates clear and September-quarter operating income reaches $163M. Conservative's opex arithmetic shows that gate is higher than I first said, so even clearing it only earns a rebuild in thirds.

Today's bar may not be final, and 233 is only 2% away. The closes will do most of the work, and I'm fine with that, because the rules are already written.

FINAL TRANSACTION PROPOSAL: SELL Aggressive Analyst: We've landed in the same place, so I'll spend this on three spots where the plan we wrote contradicts itself, one correction to my own earlier claim, and the piece I still think is worth defending.

First, Neutral, you said that above roughly a 2.6% weight the cap takes you straight to the core, so the 250-256 limits and the 233 trigger don't exist for big holders. Conservative's re-mark rule says otherwise. The same dollar budget carries about 84% of today's shares at 255, about 74% at 270, and about 61% at the 295.73 daily flip, assuming the monthly stop is still 198.17. So a big holder does have a ladder. It's built from cap re-marks instead of conviction trims. Compute that table tonight, as you said, and fold it into the 250-256 and 270 orders.

This cuts against my own side, so I'll say it plainly. The core we keep for the tail will be about 60% of its starting size by the time the tail shows up. The 24% rally to 295.73 is worth less to us than that headline sounds. I accept that, because a budget that loosens on the way up isn't a budget, but nobody should think they kept the whole move.

Second, you're right that a close-based trigger needs someone to act on the close, and I leaned on it too casually. The consequence is that staging only makes sense for a holder who can run the rule: an alert at 233 and a next-open order that same evening. A holder who can't has no 233-234 trigger, only a stop 8% away. For that holder the consistent move is to sell the trim today and keep the core. A rule you can't execute isn't a rule.

Third, the 219 trigger sits 0.39 below the August 3 low of 219.39. That wick is the one pure trap in this file, and our hair-trigger is a few cents under it. I'm fine with that only because it governs the trim and not the core. The trim is already the piece we've decided to sell, so a wick costs us a rung of the ladder, not the position. The core stays on closes for the opposite reason. Keep that division, because it's why the hybrid works.

Now my correction. I said a resting limit near 253 would have filled well above its price on the 9/21 gap. I can't support that from the file. The stock closed at 275.61 on 9/18, so it had probably crossed 253 before the Monday gap, and I have no intraday data for 9/17 or 9/18. The principle holds, since a gap-up open fills a resting limit at the open and not at the limit, and this stock has had four up days of roughly 15 to 17% since April against one 10% down day. But the example was loose.

Conservative, you're right that the 77/23 split makes the second tranche mostly a stop. Nobody here is asking anyone to lean on a bounce, and a bar that opened at 248, topped out at 250.20 and closed 0.46 off the low argues against it. The limit is an option we write for free. It isn't a forecast. It costs us something only if you hold a drift view, and that's an argument for selling, not for selling more.

I also agree with the 27^th. Neutral's check against the December 10 resolution date makes the October 27-28 recollection credible, though none of us has verified it with a tool. The trim is the piece we decided shouldn't ride a binary, and the rate market added eight points of hike odds in a week. Unless earnings turn out to be earlier than early November, the 27^th is the binding date.

What I won't give up is the core. The cap limits its size, but it doesn't make the core a trade to dump before every print. Conservative, you came around on that, and I'd hold the line. In this file the stock went from 159 to 439 and from 224 to 333, with four violent up days. A defined-loss slice of that distribution is the cheapest convexity we can own. That's why Sell is the active trade here. We're cutting an oversized position at 245x and keeping a small, capped piece of the tail.

Write the rules tonight and don't edit them after you see a price. Today, sell the larger of half the gap down to half weight and the excess over the cap, and open nothing new. Stage the rest of the trim on limits at 250-256, with no more than a tenth at 268-272, if you can run the close rule. Otherwise sell it today. Any unsold trim goes at the next open on a daily close under 233-234, or immediately on an intraday break of 219, and the limits and triggers cancel each other. Clear whatever is left by the 27^th, or a week before a verified earnings date if that's sooner. The core is the smaller of half your standard weight and the pre-computed cap table. It goes through the print, halves on a daily close under 219, and exits on a daily close under 198.17. Park the proceeds and add nothing until the filing gates clear and September-quarter operating income reaches $163M, then rebuild in thirds.

FINAL TRANSACTION PROPOSAL: SELL Aggressive Analyst: Conservative, Neutral, we're down to details, and on the ones you raised this round you're mostly right. I'll say where I'm moving and then where I'd still push.

Conservative, you win the core exit. I defended closes at 198.17 because wicks reversed at 233 and 219. But nothing since the June peak has come within about ten percent of 198, the lowest print is 219.39, and with a 17-point ATR a close under 198 could easily be 188, with the sale coming the next morning. My own test was that a rule has to work for someone who isn't watching the close, and a close-based core exit fails it. So it's a resting stop-market at 198.17. Neutral is right that it must be a stop-market and not a stop-limit, because the limit version doesn't fill on the gap we're sizing for. The half-core stop-market near 215 for holders who can't watch closes is fine too. It sits 2% under the August 3 low and about 10% below here, and a wick there costs us half of an already cap-sized core.

Neutral, you're also right about "convexity". A stop makes the payoff path dependent. If we're stopped at 198 and the stock reverses, the rebound belongs to someone else, whereas a put keeps it. What we hold is a capped-loss slice with open upside. That's still the shape I want, but it isn't convexity. Real convexity means calls, and the file has no chain, strikes or implied vol, so I'm keeping options out of the plan. If someone wants them, price them first.

On the ratchet, I'll take both your numbers: roughly 77 to 84 percent of the ride to 295.73, about 70 percent by 333, and a bit over half by 439. That's our arithmetic, not tool output. The ratchet sells shares at 255, 270 and 296, all above the 238 where we start selling. That costs us against holding everything, but it's profit-taking on the way up, and it's what a loss budget costs when it actually binds.

Part of that tax is a choice, though. A frozen 198.17 means that at 333 we'd still size as if the stop were 135 points away. The monthly SuperTrend stop only moves up while the monthly trend holds, so it can ratchet with the cap on a rule we write tonight. If a monthly bar closes with the stop higher, the stop-market and the cap's landing both move to the new value, together. They never move down, and a looser cap is never permission to buy. That gives Conservative the same number in both places. As an illustration only, if the stop had climbed to 250 by the time price reached 333, the landing would be 187.5, and the same dollar budget would carry about a quarter more shares than the frozen number. I don't know the stop will do that. The relief is also bounded, because the 25% gap convention is most of the denominator. But it's a one-way rule written in advance.

Neutral, I accept your edit test: new information, not new prices. I'd add a limit. The facts we're waiting on are the earnings date, the Fed date and the verdict form. They can move the dates and the trim, and everyone should check the first two today. They shouldn't move the cap or the stops except through that written ratchet. A friendly reading of the verdict form is exactly when someone will want to raise the cap, and that's when the cap is doing its job. An unfriendly reading needs no new rule, because the triggers already exist.

Last, priorities. We've built a dozen conditionals around a stock that moves 7% a day, and one mis-entered order on a bad day can cost more than any rung earns. Three rules carry nearly all the value: the sale today, sized by the cap or half the gap, the stop-markets on the core, and the dated clearing of the trim. The 250-256 limits, the token piece and the 233-234 trigger are free options and insurance. They're worth running if you can run them cleanly and not worth a mistake if you can't.

The thesis hasn't changed. We're cutting a 245x earnings, 49x sales, beta-3.79 name that has given back its whole September spike. A loss budget sets the size and a mild tilt sets the speed, not an edge any of us has shown. We keep a capped slice through the print because this stock has had four 15-to-17% up days since April against one 10% down day. The things that could justify rewriting the plan are the ones we don't have yet. They are the verdict form, the earnings date, whether the 77.7x forward P/E is on a GAAP basis, and what produced $270M of net income on $91M of operating income.

So here's the plan. Today, sell the larger of half the gap down to half your standard weight and the excess over the 1.3% cap, computed on the frozen 198.17 and a 148.63 landing, and open nothing new. If you can run a close rule, put most of the rest of the trim on limits at 250 to 256, with no more than a tenth at 268 to 272. The unsold trim sells at the next open on a daily close under 233-234, or immediately on an intraday break of 219, and the limits and triggers cancel each other. If you can't run that rule, sell the whole trim today. Clear whatever is left by October 27, or a week before a verified earnings date if that's sooner.

The core is the smaller of half your standard weight and the re-marked cap, with share counts at 255, 270 and 295.73 computed tonight. Those counts only loosen if the monthly stop moves up under the written rule. The core goes through the print, and a week before you ask only whether it still fits the cap. Halve it on a daily close under 219, or with a stop-market near 215 if you can't watch closes. Put a stop-market on the rest at 198.17. Park the proceeds, add nothing until the filing gates clear and September-quarter operating income reaches $163M, and then rebuild in thirds.

FINAL TRANSACTION PROPOSAL: SELL

Conservative Analyst¶

Conservative Analyst: You've argued against my position before I made it, so I'll answer you directly. We agree on the direction and on nearly every fact. Where I disagree is that I think you've talked yourself into keeping too much, and the reasons you give for keeping it are the weakest evidence in the file.

Start with the snapback. Three bounces is three observations, and the technical report itself says that doesn't establish the level will hold. Only one of those three days actually closed in the 219-226 area, at 224.89. The other two closed at 239 and 243 after intraday dips, which is roughly where we are now. We haven't tested that zone this time. And the most recent bounce attempt, 10/13, ran to 260 and was fully erased the next session. The newest evidence points the other way. The plan's own 233-234 rule would have sold that 224.89 close right before a 7% rebound. I accept that cost, because a stop that never costs you anything isn't a stop.

On the lower Bollinger band, a z-score of -2.0 exists only on the daily. Weekly is -1.05 and monthly is +0.70. RSI is 35.9, not oversold. The MACD histogram just made a new low, and the daily TD count is 5 of 9 with the weekly and monthly barely started. The daily reading is also partly an artifact. The 20-day window still contains the September spike, which is why the middle band sits at 290. Within about a week those days roll off, and a flat price will look less stretched without a single buyer showing up. That makes it a perishable signal, not a floor.

The monthly SuperTrend and the 200 SMA don't carry the weight you give them. The monthly SuperTrend stayed up through a 45.8% drawdown, so it hasn't protected anyone yet. The weekly is the primary trend, and it's down. The 200 SMA rose from 204.83 to 222.19 in a month because cheap prices from last year are dropping out of the window, not because buyers are defending it. The cash doesn't help either. $3.06B is about 1.2% of a $254B market cap, roughly $2.90 a share. It protects against insolvency, and nobody here is worried about insolvency. The risk is multiple compression, and cash doesn't address that.

Look at the payoff on the piece you want to keep. A 24% rally gets the stock back to the daily SuperTrend flip at 295.73. A 17% drop reaches the 198.17 stop, before any gap. Meanwhile the primary trend is down and opex is growing faster than revenue. Earnings are probably early November, though that date is unverified, so the remainder likely sits through a print.

On sizing, your 1.3% figure matches my math. A 25% gap through 198 means about 148.6, a 37.6% loss from here, and 0.5% divided by that is roughly 1.3% of capital. But that price isn't a tail. The stock traded at 159 in mid-April. And any position above about 2.6% of capital breaches the 1.3% cap even after a 50% cut, so the cap, not the staging, decides how much you keep. The plan's "if already at half weight, hold" can also contradict the cap. I'd write down that the tighter limit always wins, which means many holders keep far less than the plan implies.

I'd tighten the execution. Sell most of the trim now, not half of it. Aim the second tranche at 250-255 instead of 270, since 270 is 13% higher and the last two closes failed at 255. Give that tranche a date before earnings. A close-based trigger at 233-234 fires after the damage. With a 7.3% ATR, a close below 233 could be 225, and you only get out the next morning. A resting order is better, and since today's bar may not be final, build these as rules rather than pinning them to 238.

On the re-add gate, you called $163M a low bar. Check the arithmetic, which is mine and rests on one quarter's growth rates. Opex has risen every quarter in the feed since June 2025 and is $1.16B now. If it merely holds there, gross profit has to reach about $1.33B, so revenue near $1.36B, up about 5% from June with no opex growth at all. At June's growth rates I get something closer to $140M. So the remainder may be holding through a print that misses our own gate, at 245x.

The Neutral analyst hasn't spoken, but I agree with your dismissal of the sentiment data. I'd add that retail dip-buyers anchored on "$240 gap fill" with $235 stops are potential supply, not support. And we don't need the verdict form to size this. The stock fell 6.8% and the bounce failed.

So I support the Sell, with a smaller remainder, a faster exit on bounces, and a plan to cut further before earnings.

FINAL TRANSACTION PROPOSAL: SELL Conservative Analyst: We're all at Sell, so I'll start with what I'm giving up and then spend the rest on where I think you're both still holding too much hope.

Neutral is right that I dismissed the sentiment data and then used the retail stop cluster as evidence. I'm dropping that, and 233-234 stands on price structure alone, as the Aggressive now says. You're also both right that a resting order 2% under the market on a 7.3% ATR name is a noise sale. The hybrid of a close-based trigger at 233-234 and an intraday break near 219 is better than what I proposed. It isn't free, since a close trigger would have sold the 224.89 close on 7/29 right before a rebound, but I accept that cost. And a missed $163M gate means we don't add, not that the stock has to fall.

Now the point I think matters most. Aggressive, you said 233 comes before 255 about three times in four. I think that's roughly right, and it changes what the second tranche is. Three-quarters of the time it isn't a sale into a bounce, it's a stop order. Use your own numbers: 77% sold near 233, 23% sold near 253. The expected fill is about 237.6, which is today's price. Waiting buys no expected gain, only variance, and the stop sales fill the morning after a close on a stock with a 17-point ATR, so the real fill is probably under 233. If you believe in negative drift, which is the whole case for selling, the wait is a bet against your own thesis. Neutral, this also answers your point that 255 gets touched within two weeks more often than not. The question isn't whether it gets touched, it's whether it gets touched first, and with the trigger 2% away, the trigger usually goes first.

On the payoff math, Neutral's 60% and Aggressive's mid-50s both use 198 as the bad outcome. That's where the remainder's loss starts, not where it ends. The plan itself assumes a 25% gap through it, which is 148.6, and the stock traded at 159 in April. I'm not calling the gap the base case. I'm saying 17% is the kindest loss on the downside leg. On a gapped exit, my arithmetic puts the ladder's break-even at roughly a third, not the mid-50s. You both also say the real argument is the risk budget, not an expected-value contest, so let's not retreat to expected value for the pieces that favor keeping more.

Neutral, you called the risk budget the better case for selling, then said it's no reason to take the position down to the cap. That is exactly what a risk budget does. I don't know the caller's holdings, but anyone above about 2.6% of capital is over the 1.3% cap even after a full 50% cut. At a 5% allocation, a quarter now and a quarter at the bounce leaves 2.5%, nearly double the cap, with no tranche assigned to the difference. You said the excess goes in the first two tranches. Given the three-in-four point, the second tranche is mostly a stop, so the excess belongs in the first tranche, today.

Aggressive, I don't agree the verdict form is a catalyst to sell into. Neutral's own decomposition says the 6.8% drop is less than a third of the slide since 10-02. The rest is rates, oil, rotation and the spike unwinding, and reading a verdict form fixes none of that. The rate market moved the wrong way this week, with another-hike odds up 8 points to 86% and three-hike odds up about 10. Nobody here has read the form, and it could read worse than the headlines or better than the company's own statement. I'd rather not hold exposure that needs an unread document to turn out well.

On owning the tail, the same data shows 439 to 224 and 333 to 238 in three weeks. A small piece for optionality is fine and I won't fight over it. But it should sit at the cap or below, and it should be revisited a week before the print, not carried through by default. The clearing date also has to key off a verified earnings date, and early November is only recollection. Check the calendar today, and if the date is earlier, everything moves up.

So here's my version, built as rules because today's bar may be partial. - Today: Sell about three-eighths of the position instead of a quarter, or everything above the 1.3% cap if that's larger. - Second tranche: Put the rest at 250-255, where the last two closes failed. I'd drop the 268-272 piece or keep it truly token. - Triggers: Keep the close-based 233-234 trigger and the intraday 219 trigger. Pre-commit that the first executes at the next open. - Deadline: Clear whatever's unsold by October 28, or a week before the verified report date if that's sooner. - Remainder: Hold at or below the cap and exit on a daily close under 198.17. - Adds: None until the gates clear.

FINAL TRANSACTION PROPOSAL: SELL Conservative Analyst: I'll spend most of this on what you've earned, then on three loose ends in the rules we've all converged on.

Neutral, you're right that three-eighths had no derivation. The 77/23 point showed what the second tranche really is, a stop order with slippage rather than a bounce sale. It never showed that a bigger first tranche beats a quarter, and under a no-drift model nothing does. Aggressive, you're also right that slippage cuts both ways, since a gap-up open can fill a resting limit above its price. So the cost of waiting is a drift view, and I don't have enough of one to defend an extra eighth. I drop it.

I also drop the gap as a debating point. The 25% gap is a sizing convention, not a forecast, and it doesn't have to have happened in this file to be a reasonable way to set a loss budget. And I accept that a cap-sized core goes through the print. The question a week before is whether it still fits the cap, not whether to sell it.

What I keep is narrower. Nobody should count on tranche two for anything the risk budget requires, and the cap-driven sale happens today. We agree on that.

The first loose end is that the cap isn't a number you compute once. The 1.3% comes from a loss of about 89 points a share, from 238 down to 148.6. If the stock bounces to 255, where we're resting the limit orders, that loss is about 106 points a share, so the same dollar budget carries about 16% fewer shares. At 270 it's about a quarter fewer. So the bounce we hope to sell into also pushes the core over its own cap. I'd write the cap in shares, re-run it whenever price moves about an ATR, and say plainly that it only ever trims. It loosens on declines, but that must never be read as permission to buy. Aggressive, this is what a cap-sized core means in practice. It's a rule that moves with the price, not a percentage you quote and forget.

The second is how we word the first sale. "The larger of a quarter of the position and the excess over the cap" works for a holder at standard weight. The original plan, though, sells half the gap down to half weight and says hold if you're already there. A flat quarter of the holding overshoots for someone who has already trimmed, and it contradicts that hold. I'd write it as half the gap between what you hold and half your standard weight, or the excess over the cap, whichever is larger. For a standard holder that's the same quarter. For everyone else it's the same plan without a surprise.

The third is the clearing date. October 28 only works as a deadline if nothing is scheduled on it. From memory, not the tools, the Fed's October meeting wraps up on the 27^th and 28^th, and the rate market has 86% on another hike by December. If I'm right, the 28^th is decision day, and I'd rather the deadline sit on the 27^th than force a market sale into a binary. Check the Fed date today alongside the earnings date. If earnings come earlier, a week before them still wins.

One more note on waiting for the final bar. It opened at 248 and sat within half a point of the 237.55 low into the close. If that holds as final, the market has already had a full session with the verdict and the dip-buyers, and it closed on the low. That doesn't say tomorrow is lower. It does mean the newest evidence isn't a reason to lean on a bounce.

Last, a practical point. This plan has a lot of conditional pieces on a stock that moves 7% a day. Write the rules down tonight and don't edit them after you see a price. Make the resting limits and the close triggers cancel each other, so a trim can't be sold twice.

So my plan is as follows. - Today: sell the larger of half the gap down to half your standard weight and the excess over the cap, and open nothing new. - Rest of the trim: put most of it on limits at 250-256 and a token piece, a tenth at most, at 268-272. - Triggers on the unsold trim: it sells at the next open on a daily close under 233-234, or immediately on an intraday break under 219. - Deadline: clear whatever is left the day before the Fed decision, or a week before a verified report date if that's sooner. - Core: hold it at the cap, re-marked to price. Halve it on a daily close under 219 and exit the rest on a daily close under 198.17. - Cash and adds: park the proceeds, and add nothing until the filing gates clear and September-quarter operating income reaches $163M, then rebuild in thirds.

FINAL TRANSACTION PROPOSAL: SELL Conservative Analyst: We're now arguing over rungs, so I'll say what I'm taking and then spend most of my time on the one piece we've designed carelessly, which is the core.

Aggressive, you're right that big holders still have a ladder. If the cap is re-marked to price, someone above about 2.6% has rungs at 255, 270 and the 295.73 flip, sized by the loss budget instead of conviction. Neutral overstated the other side when he said nothing is left to stage. I also accept your retraction on the 9/21 fill and your point that a holder who can't run a close rule should sell the trim today.

I think you overpaid on one concession, though. You said the core will be about 60% of its starting size when the tail arrives. But the shares trimmed along the way bank their gains at 255, 270 and the flip. On your own 84, 74 and 61% steps, I get about 48.6 points of gain per original share against 57.7 unscaled by the time the stock reaches 295.73. That's roughly 84% of the ride, not 61%. This is my arithmetic, not a tool output, and it assumes a clean run. It matters because it means the ratchet is cheap, so nobody has a reason to resist it.

Neutral, the core as the smaller of half weight and the re-marked cap is right, and my "hold at the cap" was loose. Keep the 27^th, but by your own logic the open on the 28^th isn't the problem. The real reason is slack. The last day to finish clearing can't be the day you have no room if an order doesn't fill. I still can't verify the Fed date or the earnings date with a tool, so check both today.

Where I still object is the core's exit. Aggressive, your division is that the trim uses intraday triggers because a wick only costs a rung, and the core uses closes because a wick would cost the position. That holds at 233 and 219, where this file shows wicks that reversed. It doesn't carry down to 198.17. The lowest intraday price since the June peak is 219.39. The monthly stop sits about 21 points, nearly 10%, below that and about 17% below today. Nothing in almost four months of data has wicked anywhere near it, so waiting for a close protects against nothing down there, and the cost of waiting is real. With a 17-point ATR, a daily close under 198 could easily be 188, and you'd then sell the next morning, possibly lower. That is the "fires after the damage" problem I raised earlier, and your wick argument only answered it at 233.

It also fails your own executability test. A core exit that depends on someone watching the close leaves the holder who can't do that with no protection on the core at all. So I'd make the final exit a resting intraday stop at 198.17. Keep the halving at 219 on a close, since that sits inside the wick zone and the August 3 reversal is the evidence for it. The cost is a false trigger from a wick that has no precedent in the file. The benefit is that the exit starts at 198 instead of after the close. A stop won't stop a gap, which is what the sizing convention is for, but it removes one extra leg of loss we'd otherwise be choosing to take.

Second, Neutral, you wrote that the gap landing should come from the live monthly stop, while the exit is written as a fixed 198.17. Those have to be the same number. If the stop ratchets up and the cap math uses the new level while the exit stays at 198, the stated budget understates the loss we've actually signed up for. Freeze 198.17 for both tonight. If anyone wants a ratchet, write the ratchet rule for both now, not after a rally.

I'm not going to re-fight the size of the first sale or the core going through the print. The cap sets the size, the triggers set the speed, and neither of us can show an edge beyond that. A bar that opened at 248, topped out at 250.20 and closed near the low, if it's final as Neutral suggests, is a weak session and no reason to lean on a bounce.

So my plan is Neutral's one-pass plan with three changes. The final core exit is a resting intraday stop at 198.17, not a close. That same 198.17 is used in the cap math and never edited. And the plan is written in two versions, one for a holder who can run closes and alerts and one for a holder who can't. The second sells the trim today, holds only a re-marked-cap core, and relies on the intraday stop. Write the rules tonight and don't change them after you see a price.

FINAL TRANSACTION PROPOSAL: SELL Conservative Analyst: We're down to wiring, so I'll say what I'm taking and then push on a few places where the plan still reads friendlier than the file does.

Aggressive, the one-way ratchet written in advance, with the stop-market and the cap landing moving together, is what I asked for. Neutral, stop-market over stop-limit and the 215 half-core stop for anyone who can't watch closes both close real holes. I also accept your edit test, new information rather than new prices. I'm not reopening the first sale, the core going through the print, or the 25% gap as a sizing convention.

First, the ratchet will probably give back less than the illustration suggests. Aggressive, you showed the monthly stop climbing to 250 by the time price reaches 333. But that stop is 198.17 right now, after the stock traded to 452.70 in June. If the SuperTrend works the standard way and only ratchets up inside an uptrend, it sat at or below 198.17 all the way through that high. That's my inference from how the indicator normally behaves, not a tool output, but it says this stop moves slowly. So compute the share table at 255, 270 and 295.73 on the frozen 148.63 landing, and treat any relief as a bonus nobody plans around.

Second, the core's stops are not far away in this tape. Working back from the report's daily percentages, I get a close near 294.7 on 10-07, so the stock lost about 19% in five sessions. That's derived, so allow a point or so of rounding. The 215 stop is 9.7% below here, about half of last week's slide. The 198.17 stop is 16.7% below, less than another week at that pace. This doesn't change the size, since the cap was built for it, and it's why the stop-market beats a close rule. It does mean the core gets stopped if the downtrend simply continues, so it isn't a free ticket. The four big up days are real, but the window starts at 159.34, the lowest close in the file, and three of those four came during runs to new highs. The fourth, 08-04, came off a washout that traded to 219 and closed at 239. We aren't at a washout now. The weekly z-score is -1.05, RSI is 35.9 and the daily TD count is 5 of 9. That count is a reason to keep a small core. It isn't a reason to enlarge it or to hold back the trim.

Third, nobody has said that the cap is a per-name budget. Chips are falling together this week, and the sentiment feed's dip chatter included MRVL, AVGO, AMD and NVDA. If you hold other high-beta semis, the 0.5% of capital a gap is allowed to cost has to be shared across all of them, because a rotation out of chips gaps them on the same day. For many holders that's the binding number. The rule should say that if you own other high-beta chips, the cap applies to the group and the ARM core is whatever is left of it.

Fourth, Aggressive's three rules that carry the value are the sale today, the core stops and the dated clearing of the trim. The third hangs on two dates, the Fed meeting and the earnings report, and both are still from memory. Checking them is step zero, before any order goes in, because the answer can move the deadline and that's the one piece we can't improvise later. For anyone whose cap excess and trim share the 250-256 zone, make it a single order that the triggers cancel, so nothing is sold twice.

Last, a stop-out should be final until the gates clear. If the stop-market fills at 198 and the stock reverses, the rebound belongs to someone else, as Aggressive said. Nobody buys it back on feel. Re-entry comes only through the filing gates, in thirds.

So I'm endorsing Neutral's plan with these changes. Build the table on the frozen landing, share the budget across correlated chips, verify the two dates first, and use one order where one job is being done twice. Re-enter only through the gates. The sale, the stops and the clearing date carry the plan, and the 250-256 limits and the token piece are options to run only if you can run them cleanly.

FINAL TRANSACTION PROPOSAL: SELL

Neutral Analyst¶

Neutral Analyst: We all end up at Sell, so the argument is really about how. I think each of you has stretched the evidence in a different place, and I'll start with the Aggressive Analyst.

Your closing line is that if ARM rips to 295 we've given up a little, and if it breaks to 198 we've saved a lot. Run that on a half-size cut. A move to the daily SuperTrend flip at 295.73 is up about 24%, and the half you sold gives up roughly 12 points of the original position's value. A move to 198.17 is down about 17%, and the cut saves roughly 8 points. That isn't lopsided. On those two outcomes alone, selling pays only if you think the downside leg is about 60% likely. The weekly trend, the falling MACD histogram and the rate market tilt that way, but it's a tilt, not a lock. That argues for half, not more.

The better case for selling is one neither of you leads with. At beta 3.79 and a 7.3% ATR, a standard-size position is too big under almost any view. That's a risk-budget argument, and it holds even if the stock bounces tomorrow.

I'd also change your second tranche. 270 is 13% above here, while 255 is about one ATR up and where the stock closed the last two sessions. On my rough volatility math, which isn't a tool output, 255 gets touched within two weeks more often than not. 270 is closer to a coin flip, and worse if the trend stays down. So most of tranche two belongs at 250-256, with only a small last piece reaching for 270. "Within two weeks" needs to be a hard date, or it's just hope.

Conservative, you're right that three bounces is thin, and I'll give you the cash point completely. But several of your arguments cut against you.

Your payoff on the kept piece is 24% up versus 17% down. On distance alone, that favors the remainder. To argue against it you need probabilities, and the evidence only gives a lean.

On the resting order at 233, this stock traded through 233 intraday on August 3, September 1 and September 3, and closed above it every time. On August 3 the low was 219 and the close was 239, followed by a 17% day. A resting stop would have sold you at or near the low on the first of those days, ahead of a run from the 220s to 333 in about three weeks. With a 7% ATR, a stop 2% under the market is a noise sale. Your gap worry is still real. So I'd keep the close-based trigger at 233-234 for the trim and add a hard intraday trigger under the August low, around 219, which is also below the 200 SMA. That filters wicks without ignoring a real break.

On the re-add gate, missing it means we don't add. It doesn't mean the stock falls, because the stock trades on consensus, which nobody here has. And $163M is closer to a coin flip than a trap. Opex has gone 943, 1,027, 1,162 across the quarters in the feed, but revenue swings 10-15% quarter to quarter, and the implied March quarter was around $1.49B against $1.29B in June (derived, unverified). A partial rebound clears the gate. A flat quarter with rising opex misses it. That's a good reason to finish trimming before the print, which is a matter of timing. It isn't a reason to push the whole position down to the cap.

You and the Aggressive both rightly threw out the sentiment data, then brought it back as "retail stops are supply" and "a cluster of stops under the market." That's nine authors in 30 messages, in a stock that trades at least 6.5 million shares, around $1.5B, a day. Either the sentiment data is noise or it isn't.

On the verdict, you both say we don't need the form. The stock is down 22.6% since 10-02, and the 6.8% drop on 10-14 is the only slice plausibly tied to the verdict, if it landed around the 10-13 close as the retail post timing suggests. That's less than a third of the slide. The rest was rates, oil, rotation and the unwinding of the September spike. So the Aggressive is right that the multiple is the problem, and the legal piece is a smaller two-way swing factor that could reprice within days once people read the verdict form. Today's bar may also be partial, and it closed 0.46 off the low. That's why I wouldn't sell most of the trim into this print. And the absence of a bounce signal isn't a sell signal. The sell signals are the weekly trend and the histogram.

On sizing, we all get 1.3% if the rule means total loss from here to a gap at 148.6. If it means the cost of the gap beyond the stop, it's nearer 2.4%. The plan doesn't say, so write down which one you mean. The cap should beat the half-weight rule, but any excess over it should go in the first two tranches, not the last.

So my version of the plan is as follows. - Sell about a quarter of the position now, as written, and open no new position. - Split the second quarter, with most of it at 250-256 and a small last piece at 268-272. - Sell whatever remains unsold by late October, or earlier if the earnings date turns out to be sooner. - Sell the unsold trim on a daily close under 233-234, or immediately on a break under about 219. - Exit the remainder on a daily close under 198.17. - Add nothing until the filing gates clear and September-quarter operating income reaches $163M.

That cuts the risk without selling the low or reaching for a top.

FINAL TRANSACTION PROPOSAL: SELL Neutral Analyst: We're three analysts who agree on Sell and are arguing over about an eighth of a position, so I'll stick to what's still open and say where I'm changing my own earlier answer.

Conservative, you made the sharpest point of the round. With the trigger 2% away, tranche two is mostly a stop order, and a close-based stop fills the next morning, so the real fill is below 233. I accept that. But the 77/23 math proves less than you think. Under a no-drift model every schedule has the same expected fill, including selling everything today. So it can't show that three-eighths beats a quarter. It only shows that timing is a wash in expectation, which makes the choice one of regret and information. Price it with your overshoot. If the stop sales fill five points under 233, the expected fill is about 233.75 against 238 today. That costs about four points on that tranche, under half a percent of the position, and it buys a few sessions of information: the final 10-14 bar, a read of the verdict form, the next inflation print. I'd pay that. If your negative-drift lean were strong enough to make the cost large, it would justify half, not three-eighths. Three-eighths sits between my quarter and your instinct, with no derivation behind it.

You are right about the cap, though, and I'm changing my answer. I said earlier that any excess over the cap goes in the first two tranches. After what we just agreed about tranche two, that doesn't hold. The cap isn't a view on direction. It's a loss budget, and it's in force today with an ATR of 7.3% and a beta near four. We've been blending two layers. The part forced by the risk budget, everything above the cap, gets sold today with no ladder. The part driven by the technical lean, between the cap and half weight, is what we stage. So today's sale is the larger of a quarter and whatever gets you down to the cap, tested on everything still held after the sale.

Aggressive, you're right that a cap-sized core is already sized for a bad print. That answers Conservative's default of selling before earnings. A check a week before the print is fine, but the question it asks is whether the core still fits the cap, not whether to sell it. A core that has to be dumped before every event isn't a core.

Your ladder doesn't buy what you say, though. Redo the upside case with tranche two selling near 253, which is what a 250-256 order does, not 262. The forgone gain is about six points on the first quarter and four and a half on the second, so roughly ten and a half. A fall to 198 saves about eight. That puts break-even near 57%, not the mid-50s.

Conservative gets a third by swapping in a gap to 148.6, and I got 60 on a half cut. The answer swings from a third to sixty percent depending on which bad outcome you plug in. A gap to 148.6 is worse but also much rarer, so you can't pair its cost with the odds of an ordinary down-leg. That's why this isn't an expected-value contest. The risk budget sets the size, and the lean only sets the speed.

I also disagree that the verdict form is a catalyst to sell into. It's an unread document that cuts both ways. The ladder works precisely because it doesn't need us to know: the limit fills if the form reads well, and the close trigger fires if it reads badly. By your own math, the 268-272 piece fills about one time in seven before the 233 trigger. I proposed it, but it's a lottery ticket and should be sized like one, no more than a tenth of the trim.

There's a gap neither plan covers. If the 219 intraday break sells the trim, the core then sits through a break of the 200 SMA zone and the August low with nothing until 198.17, a free fall of about 10%. A single wick through 219 has reversed before, on August 3. But a daily close under 219 would be below the 224.89 close from July, the lowest close of this entire decline. I'd halve the core on that close and exit the rest on a daily close under 198.17. That keeps the tail for Aggressive without leaving the core passive through a real breakdown.

On proceeds, most of the slide since October 2 predates the verdict. The verdict explains about a quarter to a third of it, and the rest looks like rates, oil and chip rotation. Rotating into another high-beta semi rebuilds the same exposure under a different ticker, so I'd park the cash until the gates clear.

Finally, price is only 2% above the 233 line and today's bar may not be final. One or two closes may settle much of this before any of us finishes arguing.

So the plan is this. - Today: Sell the larger of a quarter of the position and the excess over the 1.3% cap. Open nothing new. - Rest of the trim: Put most of it on a limit at 250-256 and a token piece at 268-272. It sells at the next open on a daily close under 233-234, or immediately on an intraday break under 219. Clear whatever is left by October 28, or a week before a verified report date if that's sooner. - Core: Hold it at or under the cap through earnings. Halve it on a daily close under 219 and exit the rest on a daily close under 198.17. - Adds: None until the filing gates clear and September-quarter operating income reaches $163M.

FINAL TRANSACTION PROPOSAL: SELL Neutral Analyst: Here's where the three of us agree, and then the loose ends I still see.

Conservative, your rewording of the first sale beats mine. I wrote "the larger of a quarter and the excess over the cap," which contradicts the original plan's "hold if already at half weight." Half the gap down to half weight, or the excess over the cap, whichever is larger, gives a standard holder the same quarter and doesn't surprise anyone who has already trimmed. I'm adopting it.

Aggressive, you're right that waiting is a drift view, and so is not waiting. Your own distance math makes the point: 54 to 59% odds of hitting 198 before 295.73 sits right on the 57% break-even. So the sell rests on the risk budget plus a mild tilt, not on a measured edge. That's why the cap should set the size, the speed should stay modest, and none of us should defend an extra eighth.

Now the loose wiring. First, you both write the core as "at the cap," but the cap is a ceiling, not a target. Take a holder at a 1.5% standard weight. Half weight is 0.75% and the cap is about 1.3%, so "hold the core at the cap" would have them keep nearly everything. The core is the smaller of half the standard weight and the re-marked cap.

That has a bigger consequence. Above roughly a 2.6% standard weight, half weight is above the cap, so the cap-driven sale today takes you all the way to the core and nothing is left to stage. The 250-256 limits, the token piece at 268-272 and the 233-234 trigger on unsold trim only exist for holders under about 2.6%. For anyone larger, the plan is to sell to the cap today and then follow the core rules. We've spent a lot of effort tuning rungs most large holders don't have, and the plan should say so.

On re-marking, Conservative's arithmetic is right. About 89 points of loss to the 148.6 landing becomes 106 at 255 and 121 at 270. The same dollar budget therefore carries about 16% fewer shares at 255 and about a quarter fewer at 270. But "re-run whenever price moves about an ATR" on a 7% ATR name invites tinkering, and you told us yourself to write the rules tonight and not edit them. Pre-compute the share counts at 255 and 270 now. Fold the cap excess into the 250-256 order so one order does both jobs, and take the gap landing from the live monthly stop rather than a frozen number. Loosening on declines never means buying.

On the Fed, I can't verify the date from the tools either. But the hike market in the file resolves on December 10, which fits a December 8-9 meeting, and that supports your October 27-28 recollection. I'd move the deadline to the 27^th, though for a slightly different reason. Selling at the open on the 28^th wouldn't be selling into the binary. Holding the trim through the afternoon statement would be. The trim is the piece we've decided shouldn't ride a binary, and the core is sized to.

Conservative, you also read today as a full session that closed on the low. The technical report flagged the bar as possibly live because of the odd volume print. But the last StockTwits message in the sentiment feed is stamped 20:46 UTC, which is 4:46 p.m. Eastern, after the close. So a final bar is likelier than I said earlier, though I can't confirm the price file was pulled at the same moment. If it is final, your read holds: an open at 248, a high of 250.20, a close 0.46 above the low and no bounce. I'd call that a weak session, not a verdict. It's a reason not to lean on a bounce, and the plan already doesn't.

Aggressive, "the closes will do most of the work" assumes someone acts on the close. A close-based trigger needs a person to see the close and enter a next-open order, and many retail brokers don't offer a stop on the close. For a holder who can't do that, the 233-234 trigger doesn't exist, and the only mechanical backstop is the 219 intraday order, 8% below here. Your wick argument against tight intraday stops is good, but it only helps if the replacement can actually be executed. The rules need a fallback: enter the next-open sale the same evening, or set an alert with a standing instruction.

Here's the plan in one pass. The core is the smaller of half your standard weight and the re-marked cap. Today, sell the larger of half the gap down to half weight and the excess over the cap, and open nothing new. Stage any remaining trim on limits at 250-256, with no more than a tenth of it at 268-272. The unsold trim sells at the next open on a daily close under 233-234, or immediately on a break under 219. The limits and triggers cancel each other. Clear whatever is left by the 27^th, or a week before a verified earnings date if that's sooner. The core goes through the print, and a week before you ask only whether it still fits the cap. Halve the core on a daily close under 219 and exit the rest on a daily close under 198.17. Park the proceeds, add nothing until the filing gates clear and September-quarter operating income reaches $163M, and then rebuild in thirds.

FINAL TRANSACTION PROPOSAL: SELL Neutral Analyst: Aggressive, you and Conservative are each right about different halves of the ratchet. Re-marking the cap does take the share count to about 84% at 255, 74% at 270 and 61% at 295.73, which is your 60%. But the shares sold on the way up bank their gains, so the share of the move captured is higher. By my arithmetic, that's roughly 77 to 84% of the ride to 295.73, depending on how finely the rungs are spaced. That supports Conservative's point.

Neither of you mentioned that the ratchet gets more expensive the farther the rally runs. On a clean run it's closer to 70% of the ride by 333 and a bit over half by 439. That's my arithmetic, not tool output. So the cap is cheap for an ordinary rebound and a real tax on the 159-to-439 move you cite as the reason to own a core. I think that's the right price for a defined loss, but say it that way. "Convexity" is also generous. A stock position with a stop is linear with a gap tail. Real convexity means calls, and we have no strikes, expiries or implied vol to price them.

The ladder also isn't limited to holders above 2.6%. The cap shrinks as price rises, so a holder at a 2% standard weight gets caught by it around 270, and anyone above about 1.6% gets caught by the 295.73 flip. Large holders start the ratchet today and moderate ones start it higher up. The pre-computed share table covers both.

Conservative, I accept the resting stop at 198.17 for the core. Your argument beats my earlier defense of closes there. The stock was at 159 in April and insiders sold around 200 to 215 in May, so 198 is a price it has traded at this year, and it covered a lot of ground quickly in both directions. With a 17-point ATR, a close under 198 could easily be 188. I have two execution details.

First, make it a stop-market, not a stop-limit. A stop-limit doesn't fill on a gap, and the gap is what we're worried about.

Second, your two-version plan has a hole. The holder who can't run closes can't run the halving at 219, because that's a close rule. They'd go from a full core to nothing at 198, which is the roughly 10% free fall I flagged earlier. Give them a resting stop-market on half the core a bit below the August 3 wick, around 215. That's my judgment, not a derived level. It accepts that a wick through there has no precedent in this file.

I'd also soften "don't edit after you see a price." I agree for quotes. Rules shouldn't change because the stock bounced or dropped. But the earnings date, the Fed date and the verdict form are facts, and any of them should change the rules. The plan already says to check the first two today. The test for an edit is whether there's new information, not whether there's a new price.

Neither of you has made the case for more than a quarter-sized first move beyond what the cap forces, and I'm not going to either. The sell rests on the risk budget and a mild tilt from the weekly trend and the rate market. The distance math puts the odds of hitting 198 before 295.73 near the 57% break-even. So the cap sets the size and the triggers set the speed.

Here's the plan in one pass. Today, sell the larger of half the gap down to half your standard weight and the excess over the 1.3% cap. Compute the cap with the fixed 198.17 and a 148.63 landing, and open nothing new. If you can't run a close rule, sell the whole trim today. If you can, put most of the rest of the trim on limits at 250-256, with no more than a tenth at 268-272. Unsold trim sells at the next open on a daily close under 233-234, or immediately on an intraday break under 219. The limits and triggers cancel each other. Clear whatever is left by October 27, or a week before a verified earnings date if that's sooner.

The core is the smaller of half your standard weight and the re-marked cap. Compute the share counts tonight at 255, 270 and 295.73, and let the cap only ever trim. The core goes through the print, and a week before you ask only whether it still fits the cap. Halve it on a daily close under 219, or put a stop-market on half near 215 if you can't watch closes. Put a stop-market on the rest at 198.17. Park the proceeds. Add nothing until the filing gates clear and September-quarter operating income reaches $163M, then rebuild in thirds.

FINAL TRANSACTION PROPOSAL: SELL Neutral Analyst: We agree on the decision, so I'll cover what I'm taking and then three things I'd fix, one of which is an inconsistency nobody has caught.

Aggressive, your limit on the edit test is right. The earnings date, the Fed date and the verdict form can move dates and the trim. The cap is a loss budget, not a view on ARM, so a friendly verdict doesn't raise it. Only the written one-way stop ratchet does. Conservative, I'll take the correlated-chips point as one line in the rules: if you hold other high-beta semis, the 0.5% is shared and the ARM core is whatever is left. I also accept that a stop-out is final until the gates clear. And your inference about the monthly stop holds up. The SuperTrend lower band only rises in an uptrend, so 198.17 is the highest it has been in this run and it moves slowly. Write the ratchet, since it costs nothing, but don't plan around relief.

Conservative, you said three of the four big up days came during runs to new highs, so a rip needs a washout and we aren't at one. The file doesn't support that for the most recent one. The 09-21 gap of 17.2% ended with a peak of 333 against a 439 high, so it wasn't a new high. The report says RSI's 30-day low before today was 42.93, on 09-14, so that rip started from a mid-40s RSI in a downtrend with no capitulation. The 08-04 day also sits after the peak. Half the big up days came in the regime we're in now. That makes a small core reasonable, not larger, and I'm not asking for larger.

I also wouldn't treat "the core gets stopped if the downtrend continues" as an objection. That's the design. On my arithmetic, a core at the 1.33% cap stopped at 198.17 costs about 0.22% of capital, which is 1.33% times 16.7%, against 0.5% in the gap case.

Aggressive, the same file undercuts your reason for carrying the core. Four up days of 15 to 17% against one 10% down day describes the stock's range. The technical report says it doesn't know the catalyst behind any of them, so none is evidence about the print. The damage came as grinds: about 49% from 439 to 225 in six weeks, 22.6% since 10-02, and 19% in five sessions, with a worst single day of 10.1%. So the core goes through earnings because it's sized to, not because up days outnumber down days. It also means the stop-market does the real work, and the 25% gap is a loss budget, not a forecast.

Now the inconsistency. Conservative's argument at 198.17 was that a close under it could easily be 188 and the sale comes the next morning, so use a resting stop-market. Aggressive accepted that. Nobody applied the same logic to the 219 halving. The only reason for a close rule there was the August 3 wick to 219.39. A stop-market near 215 sits below every print since the June peak, so it doesn't need a close to filter wicks. A close under 219 could just as easily be 205, with the sale at the next open. So use the stop-market at 215 for everyone and drop the close-based halving. That collapses the two-version core into one.

The structure becomes three resting stop-markets: 219 on any unsold trim, 215 on half the core, and 198.17 on the rest. The 250-256 limits are linked so that when one fills, the other cancels. The only watch-dependent piece left is the optional 233-234 close trigger on the trim. A holder who can't run that should sell the trim today, as Aggressive said. This also answers his point that one mis-entered order can cost more than a rung earns.

Step zero has a third item beyond the two dates. Check the earnings date and the Fed date. From memory, the Fed meets October 27-28 and Arm reports in early November, but neither is tool-verified. Also look at what produced $270M of net income on $91M of operating income. That is a June-quarter number, so the line items should be in a report that's already out, not waiting on the print. If it's a one-off tax benefit, 245x is flattering. If it's recurring, 77.7x forward looks less alarming. Neither changes the sale, but we should know before the print, not after.

Here's the plan. Do the checks first. Today, sell the larger of half the gap down to half your standard weight and the excess over the 1.3% cap, computed on the frozen 198.17 and the 148.63 landing, and open nothing new. If you can enter an order each evening after the close, stage the rest of the trim on limits at 250 to 256, with at most a tenth at 268 to 272. Sell at the next open on a daily close under 233-234. If you can't run that, sell the trim today. Every unsold share carries the 219 stop-market, and the whole trim is gone by October 27, or a week before a verified earnings date if that's sooner.

The core is the smaller of half your standard weight and the re-marked cap, with share counts at 255, 270 and 295.73 written tonight and shared with any other high-beta chips you hold. It goes through the print. Half comes off on a stop-market near 215 and the rest on a stop-market at 198.17, never stop-limits. A stop-out is final until the gates clear. Park the proceeds. Add nothing until the filing gates clear and September-quarter operating income reaches $163M, then rebuild in thirds.

That takes out the risk the budget forces, keeps a defined slice for the upside, and doesn't require anyone to be right about direction.

FINAL TRANSACTION PROPOSAL: SELL

V. Portfolio Manager Decision¶

Portfolio Manager¶

Rating: Underweight

Executive Summary: Underweight ARM: cut toward half a standard weight, open no new position, and hold only a small loss-capped core through the early-November print. Before placing orders, verify the earnings and Fed dates and read the June-quarter filing. Today, sell the larger of (a) half the gap between your holding and half your standard weight and (b) any excess over a ~1.33%-of-capital cap; stage the rest of the trim on 250-256 limits, or sell it today if you cannot act on daily closes. Place stop-markets at 219 on any unsold trim, at ~215 on half the core and at 198.17 on the rest, clear the trim by Oct 27, and re-add only through the filing and earnings gates; the 1-3 month downside objective is 222.

Investment Thesis: Decision: Underweight, not Sell or Hold. The research plan, the trader and all three risk analysts converged on the same action: a staged trim to roughly half weight with a capped core kept. That is Underweight on this scale even though the debate labelled it SELL.

Why reduce. (1) Valuation is steep and the earnings base is unexplained. ARM trades at 245x trailing EPS, about 49x sales, 29.5x book and 77.7x forward on a $3.06 EPS whose basis is unverified. June-quarter net income of $270M came on only $91M of operating income, and nobody has explained the gap. (2) Operating deleverage. Opex grew about 28% YoY against 22% revenue growth, and operating income fell about 20% YoY to a 7.1% margin, while revenue growth slowed from +34% to +26% to +22%. (3) The tape is weak. The weekly SuperTrend is down (stop 383.15) and so is the daily (295.73). The MACD histogram is at -7.62 after eight straight declines, and price is about 12% below the 10 EMA (270.25) and 50 SMA (269.65). The stock has round-tripped the whole September spike and is 45.8% below its peak. (4) Macro is hostile: 86% odds of another hike, and beta is 3.79. (5) The argument that decided it, made by the Neutral analyst and accepted by all three, is the risk budget. With a 7.3% ATR and beta near 4, a standard-size position is too large under almost any directional view. Sizing so that a 25% gap through 198.17 (landing 148.63, a 37.6% loss from 238.01) costs no more than 0.5% of capital caps the position at about 1.33% of capital.

Why not Sell. The franchise is sound: 97.5% gross margin, about $3.06B cash, a 5.25 current ratio and $902M of June-quarter operating cash flow. The monthly SuperTrend is still up (stop 198.17), the 200 SMA (222.19) is rising below price, and the daily z-score of -2.0 puts price on the lower Bollinger band. Legal damages were nominal ($1). Most importantly, the analysts' own distance math puts the odds of hitting 198 before 295.73 at about 54-59%, right on the ~57% break-even. The tilt is mild, not an edge.

Why not Hold. The valuation, deleverage and earnings-quality concerns were deferred to filings, not refuted, and the risk-budget argument holds even if the stock bounces.

Execution, taking the strongest points from the debate: - The Conservative analyst showed that 233 is likely touched before 255 about three times in four. The second tranche is therefore mostly a stop, so nothing the risk budget requires should wait for a bounce. Cap-driven sales happen today. - The Neutral analyst's fix is adopted: resting stop-markets, never stop-limits, at 219 (trim), ~215 (half the core) and 198.17 (the rest). A close under 198 could print 188 or lower, so do not rely on the close. - Recompute the cap as price rises. It holds about 84% of today's shares at 255, 74% at 270 and 61% at 295.73. It only ever trims, and it is shared with any other high-beta semis you hold. - Keep at most a tenth of the trim at 268-272. A stop-out is final until the gates clear. Park the proceeds; do not rotate into another chip stock. - Gates for re-adding: explain the June and TTM net-over-operating gaps, stock comp at or below about a third of opex, Qualcomm exposure under 10% and undisputed, and the verdict form and docket read. Then September-quarter operating income of at least $163M, rebuilding in thirds. The base case is about $140-143M, so expect to stay reduced.

What would change the call: - Downgrade to Sell: a fill at 198.17, a post-trial ruling that limits royalty uplift, filings showing the earnings gap is mostly non-recurring, or large disputed Qualcomm exposure. - Upgrade to Hold or Overweight: all gates clean, operating income of at least $163M, and closes above 255-270.

Price target: 222, from a technical objective. A valuation objective is unusable because the forward EPS basis is unverified. Inputs: the 200 SMA at 222.19, the 219.39-225.46 cluster of prior lows (midpoint about 222.4), and close minus one ATR at 238.01 - 17.28 = 220.73. Their average is about 221.8, rounded to 222, roughly 6.7% below the close. Caveat: the 200 SMA is rising about 0.7 a day, so this support may sit near 225-226 within a week. At 222 the stock would still trade about 229x trailing and 72.5x forward, so 222 is a technical objective, not a fair-value claim.

Data gaps: consensus estimates, the earnings date, the Fed date, the verdict form and docket, the forward EPS basis, Treasury yields (FRED was unavailable), and whether the 10-14 bar is final. These lower confidence.

Current Price: 238.01

Price Target: 222.0

Confidence: Medium

Time Horizon: 1-3 months